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P1
InVivoModulation of the Expression of Genes Involved in Metastasis, Angiogenesis
and Apoptosis by Treatment with Topical Imiquimod
Hesling C.1, Mansard S.2, Souteyrand P.2, Madelmont J.-C.1,Veyre A.1, BignonY.-J.1, D’Incan M.1,2
1Molecular Oncology Laboratory/UMR484, 2Dermatology Unit, Clermont-Ferrand - France
Background: A growing body of clinical evidence exist for the e⁄cay of topical imiquimod in the
treatment of primary skin carcinomas. However, con£icting data exist concerning the interest of imi-
quimod for the treatment of skin melanoma metastases. To date, only the impact of imiquimod on
cytokines involved in immunological process have been extensively studied.
Aim: To investigate the expression of molecules involved in metastasis, angiogenesis and apoptosis
under therapy with imiquimod.
Patient and method: Topical imiquimod (1/day, 8 weeks) was applied with a dramatic response on skin
melanoma metastases in a woman. Before and after treatment, skin lesions were biopsied and the ex-
pression of the following molecules was investigated using real-time RT-PCR: metalloproteases-1,-2,-9
and their inhibitors (KISS1, TIMP1), VEGF, FGF2, angiogenesis inhibitors (THBS1, -2), p53, BCL2
and IFNg
Results: IFNg (witness fo the imiquimod activity) was upregulated under treatment.With imiquimod,
the following molecules were upregulated: TIMP1, KISS1, MMP1. MMP2 expression was not mod-
i¢ed. MMP9 expression was dramatically decreased. The expression of angiogenesis inhibitors was
slightly increased but VEGF expression remained to a basal level. The expression of BCL2 and p53
was not modi¢ed.
Comments: These results suggested that imiquimod could down-regulate metastase invasion, angiogen-
esis but not apoptosis. However, these data obtained at a transcriptional level should be con¢rmed by
migration assays in order to con¢rm that imiquimod could be safely used for the treatment of mela-
noma metastases.
P2
Lumican Decreases Tumour Growth of Mouse Melanoma
B.Vuillermoz, T. Khoruzhenko, M.-F. D’Onofrio, C. Perreau, L. Ramont, F.-X. Maquart and
Y.Wegrowski equal contribution
CNRS FRE 2534, Laboratoire de Biochimie, FaculteŁ de MeŁ decine, 51095 Reims cdx, France
Lumican is a member of a small leucine-rich proteoglycan (SLRP) family. It organizes the collagen
network and by this it plays an important role in cell migration, orientation and tissue repair. It was
recently shown that two another SLRP proteoglycans: decorin and biglycan can control tumor
growth and invasion. The present study aimed to estimate the in£uence of lumican expression on
tumour growth of mouse melanoma cells. B16F1 cells were stably transfected with an expression plas-
mid containing complete lumican cDNA. Lumican expression didn’t change the size and morphology
of the cells and the level of di¡erentiation of mouse melanoma cells. Lumican positive and lumican
negative cells produced the same quantity of melanin. Lumican didn’t change the proliferative activity
of mouse melanoma cells in monolayer culture neither in£uence cell adhesion to extracellular matrix
gel (ECM gel) or collagen type I nor cell spreading on these substrates. In contrast, lumican trans-
fected cells were characterised by essentially reduced capacity to invade ECM gel and substrate inde-
pendent migration. The number and the size of colonies formed by lumican-expressing cells in soft
agar were considerably decreased in comparison to the colonies formed by B16 F1wild type and B16F1
mock transfected cells. Lumican expression signi¢cantly decreased subcutaneous tumor formation
in vivo. The results suggest that similarly to decorin and biglycan, lumican is involved in the control
of melanoma growth and invasion and may be considered as an anti-tumor factor from the extracel-
lular matrix.
P3
Expression of ABCC6 in Human and Murine Tissues
Adeline Perrinaud1, Ludovic Martin1,2, Marc Le Bert3
1FRE 2358, Institut de transgeŁ nose, CNRS
2consultation PXE, OrleŁ ans
3CDTA-UPS 44, Institut de transgeŁ nose,
CNRS
Pseudoxanthoma elasticum (PXE) is a human disease associated with mutations in the ABCC6 gene.
The physiologic role of the ABCC6 transporter and its function in PXE remains still unknown.
Using immuno£uorescence and RT-PCR, our aim is to study the ABCC6 expression in human and
mouse (new).
Immuno£uorescence study in mouse liver, kidney, skin, eye and small intestine, and human skin
was conducted using anti-ABCC6 primary antibody and Alexa 488 conjugated secondary antibody.
Image series were recorded using a LEICA confocal microscope.
For RT-PCR, we used total RNA isolated from mouse liver, kidney and skin, and from human
skin. The primers were designed to surround exons 27 up to 30 to eliminate the background from
genomic DNA.
Results: Immuno£uorescence study in mice shows a strong staining in hepatocyte membranes with
the anti-ABCC6 antibody, and, to a lesser extend in cellular membranes of kidney. In mouse and hu-
man skins, no or a faint ABCC6 staining could be detected.
RT-PCR con¢rms these results: In liver and in kidney, ABCC6 mRNAwere detected. In skin, there
is a clear cut response compared to immuno£uorescence.
Discussion - conclusions: The ABCC6 expression studies in normal human tissues a¡ected in PXE (skin
in particular) have di¡erent results. ABCC6 protein is present in the liver and kidney of human,
mouse and rat. So there is an expression similarity through three species and a strong sequence
homology between the mice and the human ABCC6 genes. These results allow us to consider the
realisation of a mouse model of the human PXE by knocking down the mouseABCC6 gene.
P4
Phototoxicity of New Synthetic Porphyrins on Human Melanoma Cell Lines
S. Koc ak, A. Sparsa, J.F. Lagorce, F. Lamarche,V. Sol, M. Guilloton, P. Krausz, C. BeŁ dane

FaculteŁ des Sciences, Laboratoire de Chimie des Substances Naturelles, UPRES EA 1069,
Service de
Dermatologie, CHU Dupuytren, FaculteŁ de Pharmacie, Limoges, France
Photodynamic therapy relay on the use of photosensitizers which are mainly porphyrins or chlorins or
phtalocyanins which can be photoactivated and can be stored by rapidly growing tissues. First genera-
tion sensitizers lack selectivity and can induce persistent light reactions. The aim of this study was to
evaluate cytotoxicity and photocytotoxicity of synthetic polyamin porphyrins on human malanoma
cell lines.
Three melanoma cell lines were cultured using Mc Coy medium 5A, 5% CO2. Cytotoxicity and
photocytotoxicity of polyamin porphyrins were evaluated by MTS viability test. Cell lines were irra-
diated with £uorescent light source (£uence of 100 W/m2).
Ten polyamin porphyrins were evaluated from which 2 revealed photocytotoxicity at non cyto-
toxic concentrations of 106M. These phototoxicity assays induced 70 to 90% of cell death on all
three cell lines. For the remaining 8 porphyrins di¡erence between photocytotoxicity and toxicity
was not signi¢cant at 106M. Photocytotoxic activity of two protoporphyrins spermin and spermidin
was also demonstrated. Evaluation of apoptosis and necrosis induced by porphyrins will allow a better
understanding of their mechanism of action. Confocal laser scanning microscopy show their intracel-
lular localisation.
P5
18 FDG Positon Emission Tomography of Experimental B16 F10 Melanoma
Tumours
V Le Brun-Ly1, J Monteil2, J Couquet4, K Faucher3, P Rigaud3, JC Vandroux2, C Bedane1
1Service de Dermatologie, 2de MeŁ decine NucleŁ aire,
3Service de Biochimie, 4CHU Limoges, Laboratoire
DeŁ partemental D’analyse et de RechercheVeŁ teŁ rinaire
The aim of this study was to determine 18 FDG captation cinetic by murine meloma cell lines and to
di¡erentiate in£ammatory and tumoral process by early and late acquisition.
B16 F10 cells were cultured and incubated with FDG for 30, 60, 120, 300 minutes. Radioactivity
was measured by a b counter. FDG captation was then evaluated and counted on 10 wells. Cell count
was also performed within 3 di¡erent wells in parallel. After cell expansion B16 F10 cells were inocu-
lated to mice then regrafted to immunocompromized rats. Co|« ncidence detection was registered
by TEDC camera. Tumour imaging was performed on three series of 4 rats at 12,15, or 16 days post
grafting.
18 FDG imaging of tumour cells was compared to in£ammation by double early and late acquisi-
tion: one hour and 5 hours after 18 FDG injection to di¡erentiate in£ammatoty and tumoral process.
Studies of captation cinetics revealed a constant increase of capatation between 30 m and 5 h with a
maximal progression between 60 mn and 5 hours of 280%. The sensitivity of the technique allowed
the visualization of 3 mm primary or metastatic tumours. Analysis of double evaluation late versus
early acquisition revealed a signi¢cantly more important variation within the tumour group in com-
parison to the in£ammation group (po0.02).
PET imaging is a non invasive method useful for the characterization and follow up of B16 F10
tumours. 18 FDG captation kinetics are comparable in vitro and in vivo. 18 FDG PET scan of B16 F10
melanocytic tumours con¢rm a high proliferative index with a high contrast. Our results con¢rm the
interest of comparing early and late acquisition in melanoma.
P6
Use of Meta-Analysis Techniques Adapted to the Evaluation of Diagnostic Tests in
Dermatology: Application to Study the Usefulness of Lymph-Node (LN) Ultraso-
nography (US) in the Follow-up of Melanoma Stage I^II Patients
ML Bafounta, A Beauchet, P Saiag, Chu A PareŁ
UniversiteŁ Paris^Ile-France-Ouest, 92104 Boulogne F
Context: A meta-analysis is the critical review of the literature and mathematical combination of the
results of previous research, to obtain a quanti¢ed and reproducible synthesis of data, and to diminish
the bias of each study. Mostly used to assess studies on therapeutic e⁄cacy, it can also evaluate diag-
nostic tests. Such meta-analyses: 1) provide an overall summary of diagnostic accuracy; 2) determine
whether estimates of diagnostic accuracy depend on the study-design characteristics of primary stu-
dies; 3) identify areas for future research. Such a methodology has been infrequently used for skin
diseases. Our aim was to use it in assessing the value of US compared to clinical palpation in the
diagnosis of melanoma extension to LN.
Data Sources and extraction: 5 computerized databases (MEDLINE, EMBASE, PASCAL-BIOMED,
CANCERLIT and BIUM), screened to December 2002 without any language restrictions. Original
studies exploring the scope of our study were selected when comparing palpation and US with calcu-
lated or calculable values of sensitivity (Se) and speci¢city (Sp). 3 investigators extracted the data.
Results: We selected 8 studies among 88 references, which represented 2991 patients and 12741 exam-
inations (palpation vs US). All studies used high resolution US (5^15 MHz). US was performed by
experienced radiologists in 5 studies. Se of palpation ranged between 0,23 and 0,82, with Sp between
0,88 and 0,99. Se of US ranged between 0,89 and 1.00, with Sp between 0,88 and 0,99. Se of US was
4Se of palpation in 7 studies and Sp of US4 Sp of palpation in 6 studies. Statistical analysis showed
odds ratio statistically superior for US as compared to palpation (p o 0.01), with estimated positive
and negative likelihood ratios of 4.08 and 0.24 for palpation, and 41.89 and 0.024 for US, respectively.
Conclusions: US is much more e¡ective than palpation to detect melanoma LN metastases. However
there were some bias in the studies, and none demonstrated that the use of US improved patients’
survival.
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P7
Cytogenetics Abnormalities: a Predictive Factor for Tumour Relapses in Primary
CD30þ Large T-cell Lymphoma?
M. Prochazkova, E. Chevret, M. Beylot-Barry and JP Merlio
Histology and Molecular pathology laboratory, EA2406,V. Segalen University, Bordeaux, France
Whereas primary cutaneous CD30þ large T-cell (CD30þ CTCL) lymphoma is a well-de¢ned sub-
set of cutaneous lymphoma, neither genetic changes involved in its pathogenesis, nor a predictive mar-
ker for the risk of cutaneous relapse have yet been identi¢ed.
In this study, by the use of comparative genomic hybridisation (CGH) a powerful genome-scale
screening method, we analysed the DNA from thirteen CD30þ tumour biopsies in order to identify
chromosome abnormalities involved in tumour pathogenesis and relapse.
We demonstrated that chromosomal imbalances were non-randomly distributed between relapsing
and non-relapsing tumours. The mean number of changes in non-relapsing tumours was 0.33 (range,
0^1), compared with 6.29 (range, 1^16) in relapsing tumours. The recurrent chromosomes involved in
relapsing cases were chromosomes 6 (86%), 9 (86%) and 18 (43%).While chromosome 9 was mostly
a¡ected by gain, chromosomes 6 and 18 mainly contained regions of loss, exclusively on 6q and 18p
arms.
Although further studies are required to increase the number of CD30þ CTCL analysed and to
delimit the minimal region of deletion on chromosomes 6 and 18; for the ¢rst time, our data provide
original insight into chromosomal events that may be involved in the pathogenesis of CD30þ CTCL
relapses and that may identify patients at risk for relapse.
P8
Germline Mutations of the INK4a-ARF Gene in Patients with Suspected Genetic
Predisposition to Melanoma
N Sou¢r1, J J Lacapere2, G Bertrand1, E Matichard1, R Meziani1, D Mirebeau3,V Descamps4, B GeŁ rard
1,
A Archimbaud5, L Ollivaud5, F Bouscarat, M Baccard5, G Lanternier6, C LebbeŁ
5, N Basset-Seguin5,
B Crickx4, H Cave3 and B Grandchamp1
1Laboratoire de Biochimie-GeŁ neŁ tique,
2Inserm U 410 FaculteŁ Bichat-Claude Bernard, Paris,
3Laboratoire de
Biochimie-GeŁ neŁ tique, HoŒ pital Robert DebreŁ, Paris,
4Service de Dermatologie, HoŒ pital Bichat-Claude Bernard, Paris,
France, 5Service de Dermatologie, HoŒ pital Saint-Louis, Paris,
6Service de Dermatologie, HoŒ pital Percy, Clamart,
France
Germline anomalies of the INK4a-ARF and Cdk4 genes were sought in a series of eighty-nine patients
suspected of having a genetic predisposition to melanoma. Patients were selected on the following
criteria: (a) familial melanoma (23 cases), (b) multiple primary melanoma (MPM) (18 cases), (c) mel-
anoma and additional unrelated cancers (13 cases), (d) age at diagnosis less than 25 years (21 cases), and
(e) non-photo-induced melanoma (NPIM) (14 cases). Mutations of INK4a-ARF and Cdk4 were char-
acterized by automated sequencing, and germline deletions of INK4a-ARF were also examined by
real time quantitative PCR. Seven germline changes of INK4a-ARF, ¢ve of which were novel, were
found in seven patients (8%). Four were very likely to be pathogenic mutations and were found in
three high-risk melanoma families and in a patient that had a pancreatic carcinoma in addition to
melanoma. Three variants of uncertain signi¢cance were detected in one MPM patient, one patient
o25 years, and one NPIM patient. No germline deletion of INK4a-ARF was found in 71 patients,
and no Cdk4 mutation was observed in the 89 patients. This study con¢rms that INK4a-ARF muta-
tions are infrequent outside stringent familial criteria, and that germline INK4a-ARF deletions are
rarely involved in genetic predisposition to melanoma.
P9
BRAF as a Melanoma Susceptibility Candidate Gene?
K. Laud1, C. Kannengiesser1, MFAvril1, A. Chompret1, D. Stoppa-Lyonnet2, L. Desjardins2, A. Eychene3,
F. Demenais4, G.M Lenoir1 and B. Bressac-de Paillerets1
1Institut Gustave Roussy,Villejuif, France; 2Institut Curie, Paris, France; 3CNRS UMR146, Orsay, France;
4INSERM-UniversiteŁ d’Evry, France
The Ras-Raf-MEK-ERK pathway mediates cellular responses to growth signals. In melanocytes, this
pathway plays a major role in the proliferation and melanogenesis in response to ultraviolet A/B radia-
tion via the activation of two speci¢c kinases: BRAF and ERK. A high frequency of activating BRAF
somatic mutations have recently been identi¢ed in malignant melanoma (66%). All mutations are
within the kinase domain, with a hotspot single substitution V599E in exon 5 detected in 80% of
nevi and primary melanoma and in 60% of melanoma cell lines. These data indicate that BRAF acti-
vation can represent an early and critical step in the initiation of melanocytic neoplasia.We hypothe-
sized that BRAF could be a melanoma susceptibility gene.
To evaluate the BRAF gene as a candidate in melanoma predisposition, we screened the entire
BRAF coding region (Exon 1 to 18) for germline mutations in 80 independent melanoma families
or patients by sequencing analysis and Denaturating High-Performance Liquid Chromatography
(dHPLC) analysis. Patients tested were either index cases in melanoma-prone families or patients with
multiple primary melanoma without a familial history.
We identi¢ed 13 BRAF variants, 4 of which were silent mutations in coding regions and 9 nucleo-
tide substitutions in introns. None of these BRAF variants segregated with melanoma in the 11
melanoma families studied. Moreover, there was no signi¢cant di¡erence in the frequency of
heterozygotes for BRAF variant between melanoma cases and controls groups when they were
compared.
Our data suggest that BRAF is unlikely to be a melanoma susceptibility gene.
P10
Association of the ASIP Exon 3’UTR Polymorphism in the French Population
with Dark Hair and Skin Color, but Not with Melanoma Risk
Meziani R1, Matichard E1,Verpillat P2, Descamps V3, Bertrand G1, GeŁ rard B
1, Archimbaud A4, Picard
C2, Olliveau L4, Basset-Seguin N4, Crickx B3 et Grandchamp B1, Sou¢r N1
1Laboratoire de Biochimie-GeŁ neŁ tique, HoŒ pital Bichat-Claude Bernard;
2Service de Biostatistiques, HoŒ pital Bichat-
Claude Bernard; 3Service de Dermatologie, HoŒ pital Bichat-Claude Bernard;
4Service de Dermatologie, HoŒ pital
Saint-Louis
The agouti signaling protein gene (ASIP) has been recently associated with human pigmentation.We
sought to characterize it in a group of white French Caucasian subjects, to assess whetherASIP was a
determinant of human pigmentation and whether this gene may be associated with increased mela-
noma risk.We studied 115 melanoma patients and 105 controls without personal and family history of
skin cancer for the ASIP gene, by means of polymerase chain reaction and automated sequencing.We
con¢rmed the presence of the 8818AG polymorphism in the 3 untranslated region and also found two
other polymorphisms, a silent change in the coding-region sequence variation in ASIP, and a rare C/T
polymorphism in the 3’UTR. Among the 105 control subjects, the frequency of theASIP 8818G allele
was .12. Carriage of the G allele was signi¢cantly associated with dark hair (p¼ 0.005) dark skin
(p¼ 0.003), and with skin type 3 or 4 (p¼ 0.039), but was not associated independently with disease
status, or with nevus count, lentigines, or eye color. Our data con¢rm the association of ASIP exon
3 polymorphism with dark human pigmentation characteristics in a French ethnically di¡erent
population.
P11
Biochemical Characterization and Cellular Distribution of CGI-58 Protein
Mutated in Dorfman-Chanarin Syndrome
F. Caux1, Z. Ben Selma1, J. Fischer2, L. Laroche1
1Service de Dermatologie et UPRES EA 3408, C.H.U., 93000 Bobigny; 2Centre National de GeŁ notypage, 91000
Evry, France
Dorfman-Chanarin syndrome (DCS) is a recessive disease characterized by an ichthyosiform erythro-
derma associated with a di¡use tissular accumulation of triacylglycerol.We have previously identi¢ed
mutations in a new gene, CGI-58, in DCS. However, cellular distribution of CGI-58 protein encoded
by this gene is unknown and structural data on the protein are needed.
Polyclonal antibodies to the N- and C-terminal domains of CGI-58 protein were elicited in NZW
rabbits by injections of synthetic peptides of 13 and 14 amino acids conjugated via a terminal cysteine
residue to hemocyanin. Indirect immuno£uorescence (IIF) and immunoblotting were performed
using rabbit sera before and after 4 immunizations.
Using IIF, a di¡use but predominantly perinuclear cytoplasmic staining was observed on cultures
of human skin ¢broblasts, keratinocytes and Hela cells with both sera. A cytoplasmic staining of ker-
atinocytes in all epidermal layers, although more intense in the corni¢ed one was demonstrated by IIF
on normal human skin.
A 66 kDa protein was detected in extracts of human ¢broblasts, lymphocytes and polymorpho-
nuclears under reducing and denaturating conditions.
The cytoplasmic and perinuclear location of CGI-58 protein is in accordance with the site of accu-
mulation of triacylglycerol in DCS. Since the molecular weight of the amino acid sequence of CGI-
58 is evaluated at 39 kDa, the value of apparent molecular weight observed by immunoblotting is in
favor of extensive post translational modi¢cations which may represent 40% of the molecular weight
of CGI-58 protein.
P12
Neuronal Ceroid-Lipofuscinosis: Clinical, Ultrastructural and Genetic Characteris-
tics in Infantil and Juvenil Forms
P Courville1, D Parain1, A Gelot2, C Caillaud3, D Genty1, E Thomine1
1Rouen and 2,3Paris University Hospitals - France
Neuronal Ceroid-lipofuscinosis (NCL) is an inherited degenerative disease characterized by loss of
neurons and lysosomal accumulation of auto£uorescent storage material in various tissues.
We describe two cases of NCL, juvenile and infantile types. Clinical presentation, ultrastructural
characteristics from fresh skin biopsies (pre¢xed in 2% glutaraldehyde and post¢xed in 1% osmium
tetroxide) and analysis of CLN genes from peripheral lymphocytes were evaluated.
Case 1 concerned a 14 year old boy who had a normal development until 10 years of age. He pro-
gressively developed seizure, a visual defect due to retinal pigment degeneration and mental retarda-
tion. On electron microscopy, inclusions with ¢ngerprints and curvilinear bodies characteristics were
observed in ¢broblasts, endothelial and Schwann cells.
Case 2 concerned a 3 year-old boy referred to the Neurology department for severe psychomotor
retardation. Ultrastructure analysis showed osmiophilic lysosomal storage due to a granular osmiophi-
lic deposit Mutation of CLN1 gene on 1p32 chromosome was found in both the patient and his par-
ents.
Clinicopathological and genetic studies have demonstrated that NCL are a group of heterogeneous
disorders. In ¢ve of the eight NCL distinguished at present, genes have been characterized
(CLN1,2,3,5,8). Despite recent advances in immunohistochemical detection of biochemical markers,
ultrastructural identi¢cation of ceroid lipofuscin remains the gold standard for the diagnosis of NCL
with the clinical features and respective gene defects.
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Biochemical Analysis of the KM48 Antigen: a New Epidermal Proteoglycan?
Duhieu S, Laperdrix C, Bernard D, Schmidt R, Schmitt D, Haftek M.
Unit 346 INSERM/CNRS, Hospital E. Herriot, 69437 Lyon and L’OreŁ al Recherche, Centre C. Zviak, Clichy,
France
The KM48 antigen has been initially described in human keratinocyte suspensions as associated with
desmosomes and expressed in a manner strictly following the degree of epidermal di¡erentiation. In a
previous study, we have demonstrated the absence of cross-reactivity of KM48 antibody with desmo-
somal cadherins.
Using the KM48 monoclonal antibody (IgM) for ultrastructural labelling of skin ultracryosections,
we could detect the presence of the antigen in the intercellular spaces of the epidermis. However, no
reactivity of desmosomes was present unless these junctions became dissociated with trypsin. The
SDS-PAGE pro¢le of epidermal protein extracts obtained with non-ionic detergents, revealed a
KM48 -reactive smear at a high molecular range, around 200 kDa, typical of glycosilated proteins.
Chemical deglycosilation with tri£uoromethane sulphonic acid reduced the size of the KM48-reactive
band to 70 kDa. Such a proportion between the protein and sugar parts of the molecule is highly
characteristic of proteoglycans. Accordingly, enzymatic digestions targeting various types of glycosa-
minoglycan chains con¢rmed the presence of sugar polymers of chondroitin sulphate - dermatan sul-
phate type. Immunoprecipitation experiments with KM48 antibody resulted in the detection of a
speci¢c band at 100 kDa. The KM48 -immunoprecipitated proteins were not reactive with antibodies
directed against syndecan-1 and CD44, which present a similar, but not identical, tissue distribution as
KM48.
We suggest that our KM48 antibody detects a new epidermal proteoglycan expressed in the inter-
keratinocyte spaces. This assumption will be veri¢ed by ongoing protein sequencing studies.
P14
A New Clinical Condition Linked to a Novel Mutation in Lamins A and C with
Generalized Lipoatrophy, Disseminated Leucomelanodermic Papules, Insulin-Re-
sistant Diabetes, Liver Steatosis and Cardiomyopathy
F. Caux1, E. Dubosclard2, O. Lascols2,3, B. Buendia4, O. Chazouilleres5, A. Cohen6, J.-C. Courvalin4,
J. Capeau2, C.Vigouroux2, S. Christin-Maitre7, L. Laroche1
1Service de Dermatologie et UPRES EA 3408, C.H.U., Bobigny; 2INSERMU402, 3Laboratoire de Biologie
MoleŁ culaire,
4Laboratoire de Biologie Cellulaire, Institut Jacques Monod; 5Services d’HeŁ patologie,
6Cardiologie et
Endocrinologie7, HoŒ pital Saint-Antoine, Paris, France
The LMNA gene located on chromosome 1q21-22 gives rise to lamins A and C. These proteins are
ubiquitously expressed and belong to the intermediate ¢laments proteins. They copolymerize with
B-type lamins to form the lamina, a nuclear network located between the inner nuclear membrane
and chromatin.
Naturally occurring mutations in these proteins have been shown to be responsible for several dis-
tinct diseases which display skeletal and/or cardiac muscle or peripheral nerve involvement. These in-
clude the familial partial lipodystrophy of the Dunnigan type, and the mandibuloacral dysplasia
syndrome. The pathophysiology of this group of diseases associated with various clinical manifesta-
tions, often referred to as laminopathies, remains elusive.
We report a new condition in a 30-year-old man exhibiting a previously undescribed heterozygous
R133L LMNA mutation. His phenotype associated a generalized acquired lipoatrophy with insulin
resistant diabetes, disseminated whitish papules on pigmented skin, hepatic steatosis and hypertrophic
cardiomyopathy with valvular involvement. This case is sporadic resulting of de novo mutation since
the R133L LMNA mutation was not found in patient’s family. Immuno£uorescence microscopic ana-
lysis of the shape and constituents of nuclear membrane (lamins A, B, C, emerin) using the patient’s
skin ¢broblasts revealed a nuclear disorganization with herniations in 15% of cells, contrasting with a
normal staining on his skin and liver biopsies. Moreover an abnormal distribution of lamins A and C
with honeycomb aspect of nuclei was observed in 8% of ¢broblasts and was similar to that observed
in patients harboring other LMNA mutations. Lamins A, B, C and emerin expression in whole ¢bro-
blasts extracts from the patient and controls was normal byWestern blot.
This observation broadens the clinical spectrum of laminopathies including hypertrophic cardio-
myopathy as well as generalized lipoatrophy. It points out the skin as an additional potential target
tissue of LMNA mutations.
Reference: Caux F., et al. J Clin Endocrinol Metab. 2003, 88: 1006^1013.
P15
Large Scale Genomic Approach to Identify Diagnostic/Prognostic Marker and
Drug Target Candidate Genes Linked to Skin Diseases
B. Peters1, D. Freiho¡1, J.M. Baron2, C. Mauch3, J.Wenzel4, H. Merk2,T. Bieber4,T. Krieg3, A. Bosio1
1Memorec Sto¡el GmbH, StoeckheimerWeg 1, D-50829 Cologne; 2Department of Dermatology, University
of Aachen, Pauwelsstr. 30, D-52074 Aachen; 3Department of Dermatology, University of Cologne, Joseph-
Stelzmann- Str. 9, D-50931 Cologne; 4Department of Dermatology, University of Bonn, Sigmund- Freud- Str. 25,
D- 53105 Bonn
The aim of our studies is to identify drug target candidate genes and diagnostic/prognostic marker
genes linked to in£ammatory skin diseases and skin cancers. In a pilot project, we constructed two
SAGE libraries (30000 tags) using RNA of 21 psoriasis biopsies and of 22 healthy individuals respec-
tively. Comparison of the two SAGE libraries revealed about 70 di¡erentially (42-fold, po0.01) ex-
pressed genes, some of them already known to be associated with psoriasis, like protease inhibitor 3,
keratin 6A or the S100 calcium binding proteins, e.g. psoriasin 1, while a maximum of 10% of the
genes has not been named in the context of the disease before.
Con¢rmation of our results was achieved using the PIQORt array technology. Each of the psor-
iasis biopsies and the healthy controls were hybridized versus a common reference on PIQORt
Skin1.0 arrays. The PIQORtSkin1.0 array comprises about 1300 genes expressed in human skin dis-
eases or normal skin. The expression pro¢les of individual patients allowed us to distinguish between
genes di¡erentially expressed in individuals or subgroups, and putative universal marker genes for
psoriasis. Our results clearly demonstrate that SAGE data from pooled samples should always be con-
¢rmed by analysis of individual biopsies. Otherwise the identi¢cation of putative marker genes allow-
ing a new pathological classi¢cation of the disease might be missed or individual di¡erences in gene
expression might be misinterpreted as universal.
Key words: Psoriasis, transcriptome, microarray
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Abnormal Proteolysis of Corneodesmosin in Psoriatic Skin
M. Simon1, R. Tazi-Ahnini2, M. J. Cork2, and G. Serre1
1CNRS FRE 2623,Toulouse, France and 2Division of Molecular and Genetic Medicine, University of She⁄eld, UK
The CDSN gene, located in the PSORS1 locus, appears to be a strong candidate for predisposition to
familial psoriasis. Corneo-desmosin (CDSN), the 52-56 kDa protein encoded by CDSN, is an adhe-
sive extracellular component of corneodesmosomes. Particular allelic variants of CDSN have been
shown to be associated with psoriasis, some associated SNPs modifying potential protease cleavage
sites on the protein.We tested whether the proteolytic maturation and the degradation of CDSN ob-
served in the normal stratum corneum are impaired in psoriatic epidermis.
Total protein extracts of tape-strippings obtained from non-lesional (NL) and lesional (L) skin of 11
psoriasis patients were analysed byWestern blotting with anti-peptide antibodies directed to various do-
mains of CDSN. Results were compared to those obtained with tape-stripping extracts of normal skin.
Abnormal and reduced proteolysis of CDSN was observed in most L compared to NL or normal
skin extracts. Indeed, a quasi-entire form of CDSN and high molecular weight fragments were highly
detected by the antibodies speci¢c for the most amino- and the most carboxy-terminal domains of
CDSN in all L skin extracts, whereas they were only slightly detected or undetected in NL skin ex-
tracts, and never detected in normal skin extracts. To test whether expression of SCCE, one of the
proteases involved in CDSN proteolysis and in desquamation, is reduced in psoriasis, the extracts were
also analysed with antibodies directed against the protease. Similar or higher amounts of both pro-
SCCE and SCCE were detected in L skin extracts compared to NL or normal skin extracts.
Our results provided evidence of altered proteolysis of CDSN in psoriasis, consistent with involve-
ment of the protein in the disease pathogenesis.
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Alefacept Selectively Targets E¡ector Memory (TEM) and Type 1 T-cells, but
Spares Central Memory (Tcm) and Na|« ve Populations
J Krueger,T Kikuchi, F Chamian, P Gilleaudeau, M Sullivan-Whalen, F Chu, M Kagen, E Lee
The Rockefeller University, NewYork, NewYork, USA
Within CD4þ and CD8þ T-cell populations, memoryT-cells di¡erentiate into specialized subsets
with distinct functions. Central memory (Tcm) T-cells maintain immune surveillance by constant
recirculation between peripheral blood and lymph nodes. This group of CD45RA- T-cells express
the chemokine receptor CCR7 and responds to chemokines made selectively in lymph nodes. In con-
trast, memoryT-cells that function as e¡ectors in peripheral tissues do not express CCR7, but instead
have gained other receptors such as CLA,VLA-4, and CXCR3 that target T-cells to in£amed periph-
eral tissues. These cells are termed e¡ector memory (Tem) T-cells. Most g-interferon producing or
Type 1 T-cells belong to the Tem subset.We determined that CD2 (the main binding target of alefa-
cept) is expressed at lowest levels on Na|«ve T-cells, intermediate levels on Tcm T-cells, and highest
levels on Tem T-cells in psoriasis patients. The e¡ect of alefacept on subpopulations of CD4þ and
CD8þ memoryT-cells was followed in 22 patients treated weekly with 7.5 mg of this agent using
4-color £ow cytometry. Populations studied included na|«ve (CD45RAþCCR7þ ), Tcmcentral
memory (CC45RA-CCR7þ ) & Teme¡ector memory (CD45RA-CCR7-) T-cells in both
CD4þ and CD8þ subsets. In addition, populations expressing other memory-related proteins in-
cluding CD27, CLA, LFA-1,VLA-4, & ab7 integrin were quanti¢ed by 4-color £ow cytometry dur-
ing 13 weeks of initial treatment. Finally, the frequency of circulatingType-1 (g-interferon producing)
or Type-2 (IL-4 producing) T-cells was measured by intracellular staining after activation of T-cells
with phorbol and ionomycin. Speci¢c memory populations of T-cells (especially CD4þ Tem,
CD8þ Tem, and CD8þ memory (CD27þCD45RA-) were strongly and selectively decreased by
alefacept. The largest decrease in a de¢ned T-cell population occurred in CD8þCD27þCD45RA-
lymphocytes, a population of memory CD8þ T-cells that selectively accumulates in psoriasis skin
lesions. In addition, alefacept produced a mean decrease of 58% inType 1 T-cells (po0.0001), but only
a 29% mean decrease in Type 2 T-cells (p¼ 0.07). The selective depletion of Type 1^cells largely nor-
malized the Type1/Type2 imbalance that occurs in untreated psoriasis patients.We conclude that dis-
ease-related memory populations of CD4þ and CD8þ T-cells are selectively targeted by alefacept,
while long-term memory (Tcm) T-cells and Type 2 T-cells are relatively spared.
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Alefacept Treatment Results in Clinically Meaningful Improvement in Patients
with Chronic Plaque Psoriasis: Results from Two Randomized, Placebo-Con-
trolled Phase III Trials
R Balkrishnan, PhD, SR Feldman, MD
Wake Forest University School of Medicine,Winston-Salem, NC
Psoriasis profoundly a¡ects patient quality of life (QOL). QOL measures can test whether treatment
improves patients’ lives and can be used to demonstrate that clinically meaningful improvement has
been achieved. Two randomized, placebo-controlled phase 3 trials including 41000 patients with
chronic plaque psoriasis demonstrated the e⁄cacy and safety of alefacept (human LFA-3/IgG1 fusion
protein) when administered weekly by intravenous (IV; 7.5 mg by 30-second bolus) or intramuscular
(IM; 10 or 15 mg) injection. Patients in the IM study received one 12-week course of study drug; in the
IV study, patients received 2 courses of therapy, separated by Z12 weeks. QOL was prospectively as-
sessed with 2 dermatology-speci¢c measures. The Dermatology Life Quality Index (DLQI) is a vali-
dated 10-item survey with a scale of 0-30 that addresses the impact of psoriasis on work, leisure and
daily activities, personal relationships, symptoms/feelings, and treatment-related distress. The Derma-
tology Quality of Life Scales (DQOLS) includes 41 items, comprising 3 scales (Psychosocial, Activ-
ities, Symptoms) that range from 0-100. Higher scores indicate greater QOL impairment. For the
DLQI Overall scale, patients receiving 7.5 mg IV or 15 mg IM alefacept reported improvements from
baseline of 39% and 41% versus placebo improvements from baseline of 16% (Po.001) and 25%
(Po.001), respectively. Patients receiving 7.5 mg IV alefacept reported signi¢cant mean improvements
in DQOLS scores versus placebo as assessed by the Psychosocial (10.8 vs 6.1, P¼.005), Activities (10.4
vs 4.9, Po.0001), and Symptoms (19.9 vs 9.2, Po.0001) scales, with similar levels of improvement in
patients receiving 15 mg IM alefacept. The signi¢cant improvement in QOL for responders, de¢ned as
a X75% PASI reduction, was sustained forZ12 weeks after the last alefacept dose by either route of
administration. In addition, signi¢cant improvement in QOL was reported for patients who had a
X50% decrease in PASI and this improvement was sustained for Z12 weeks after the last alefacept
dose. The majority of QOL improvement was noted with a 50% reduction in PASI, con¢rming that a
decrease of 50% of PASI from baseline is clinically signi¢cant. Alefacept is well tolerated and provides
clinically meaningful improvements in QOL according to 2 validated QOL scales.
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Elaidyl-lysyl-phenylalanyl-lysin (Lipospondin) as a Model Compound to Prevent
Aging-Associated Dermal Alterations
J.H. Cauchard1, A. Berton2, G. Godeau3, P. Bernard1,W. Hornebeck1, G. Bellon1
1Laboratory of Biochemistry, FRE 2534 CNRS, IFR-53 Biomolecules, UniversiteŁ de Reims Champagne-Ardennes,
FaculteŁ de MeŁ dicine, 51 Rue Cognacq Jay, 51095 Reims cedex, France;
2Cell Unit, UniversiteŁ Catholique de
Louvain, ICP/Cell 75, 75 Avenue Hippocrate, B-1200, Bruxelles, Belgique; 3Laboratory of Biochemistry, Faculty of
Odonthology, ParisV, F-92120 Montrouge, France
The conspicuous alterations of dermal collagen and elastin ¢bers is a hallmark of either intrinsic or
extrinsic skin aging. Those changes are attributed to the cooperative action of matrix metalloprotei-
nases (MMPs), an enzyme family comprising 26 members. Control of MMPs may be exerted at their
expression, activation or activity levels.
We designed a model bifunctional molecule which can, on our side, down regulate and up regulate
the expression of MMP-1 and tissue inhibitor of metalloprotease-1 (TIMP-1), respectively, by human
dermal ¢broblasts, through proTGFb activation, and on its other part acts as an MMP inhibitor. Thus,
a tripeptide sequence i.e. KFK present in thrombospondin-1 which was reported to activate latent
TGF-b was covalently linked to elaidic acid, a long chain unsaturated acid, in keeping with the ability
of those lipids to inhibit MMP activity. Elaidyl-Lysyl-Phenylalanyl-Lysin, we designated as Lipospon-
din, proved to activate pro-TGFb both in-vitro and ex-vivo in human dermal ¢broblast cultures repro-
ducing the bene¢cial in£uence of active TGFb on MMP-1/TIMP-1 balance. Importantly, its
inhibitory capacity toward MMP activity, assessed in-vitro assay quenched £uorescent peptide sub-
strate or ex-vivo on human skin tissues sections, was majorly improved as composed to unmodi¢ed
fatty acid.
Since lipospondin also enhance collagen biosynthesis, it must be considered as a promising com-
pound to simultaneously impair matrix degradation and favor its repair, thus conectivy dermal altera-
tions associated with skin aging.
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Cytokine production pro¢le of peripheral blood Tcells in bullous pemphigoid
Serge Jacquot1,2, Danie' le Gilbert1,2, Ingrid Dutot2, Pascal Joly1,3, Franc ois Tron1,2
1Inserm U.519, IFRMP23, 2Laboratoire d’Immunopathologie Clinique et ExpeŁ rimentale,
3Clinique
Dermatologique; CHU Charles Nicolle, FaculteŁ de MeŁ decine et de Pharmacie. 22, boulevard Gambetta, Rouen, 76
183 cedex1 France
Introduction: Since T-cells providing B cell help for pathogenic auto-antibody production may recir-
culate, we characterized the cytokine production pro¢le of peripheral blood T lymphocytes after
in vitro activation in patients with bullous pemphigoid.
Material and methods: Peripheral blood was obtained from 15 bullous pemphigoid patients (7 males, 8
females, age 77-89 years) and 7 controls free of immunologic or in£ammatory diseases (3 males, 4
females, age 81-92 years).Whole blood cells were activated overnight with Phorbol Myristate Acetate
(50 ng/ml) and Ionomycin (500 ng/ml) in presence of Brefeldin A (10mg/ml). T cell cytokine produc-
tion was then analyzed by £ow cytometry after membrane staining with £uorescent labelled CD3 and
CD8 monoclonal antibodies, cell permeabilization and cytoplasmic staining with phycoerythrin-la-
belled monoclonal antibodies speci¢c for representative cytokines. Results are given as percentages of
cytokine producing cells in CD3þCD8 and in CD3þCD8þ gated T-cells.
Results: In both patients and controls, IL2-producingTVcells were found mainly in the CD8 subsets
(ie CD4þ Tcells) whereas IFNg and TNF- producingTVcells predominated in the CD8þ subset. In
contrast, IL4- and IL10-producing T cells were hardly detectable in patients and controls as well.
Conclusion: Circulating T cells in bullous pemphigoid display a marked Th1 type cytokine production
pro¢le. This pro¢le may be related to changes observed in ageing individuals. However, were these
cells shown to be involved in auto-antigen recognition, their Th1 cytokine production could contri-
bute to the isotype choice for auto-antibodies.
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New autoantigen identi¢cation in autoimmune bullous skin diseases
H. Mouquet,V. Saulot, F. Bayeux-Bonnet, P. Joly, F. Tron and D. Gilbert
U519 INSERM, IFR 23 and service de Dermatologie, CHU Charles Nicolle Rouen-France
In order to identify new antigen/antibody pairs in autoimmune diseases, we have set up a program
called ACPRA (Autoantigen Characterization by Proteomic and Recombinant Analysis) based on
proteomic maps and cDNA expression library immuno-screening. Candidate sera or monoclonal
autoantibodies (mAb) were selected when showing an unknown staining pattern in indirect immu-
no£uorescence analysis (IIF) or unknown polypeptide reactivity by western blot.We were particularly
interested in testing mAb F12 and sera recognizing 180-190 kD polypeptides.
By screening a keratinocyte cDNA expression library, we have identi¢ed a cDNA encoding for the
Eps15 protein, an EGF receptor substrate. This 140 kDa protein was recognized by mAb F12 and some
sera from paraneoplastic pemphigus patients. However, this autoantigen did not represent the main
target of mAb F12, since F12 mainly binds to a 185 kD polypeptide in western blot and shows an IIF
staining pattern di¡erent from that given by an anti-Eps15 mAb.
We have also found a new target for autoantibodies present in sera from 3 patients with a unusual
bullous skin disease (lichenoid erythrodermic bullous pemphigoid). Sequence analysis of the cDNA
clone allowed us to identify IQGAPI which codes for a 180 kDa protein. IQGAP I is an activating
molecule for the Rho family Ras GTPases Cdc 42 and Rac1 controlling E-cadherin expression. This
new autoantigen was recently described in bullous pemphigoid patients.
Diagnostic value of these two new autoantibody populations still remains to be de¢ned.
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Acute Generalized Exanthematous Pustulosis. Analysis of Clinical Data and Non
Drug Risk Factors from EuroSCAR Study
Sassolas B, Sidoro¡ A, Halevy S, Bazin F, Naldi L, Dunant A, Roujeau JC
Department of Dermatology, CHU Brest, France and the EuroSCAR study group
Generalized Exanthematous Pustulosis (AGEP) was among the pustular eruptions de¢ned in the early
1980s. This reaction, mainly drug induced, is characterised by the acute onset of dozens to hundreds of
small, pinhead-sized non-follicular sterile pustules. They often arise on an edematous erythema, with
accentuation of lesions in big folds. Recognition of this disease and its separation from acute pustular
psoriasis is not worldwide.
During a 5 year-period, in a multinational case control study (EuroSCAR) based on a European
detection network devoted to study severe cutaneous adverse reactions, we actively detected cases of
acute pustular eruption.We recorded demographic data, previous medical history, clinical and histo-
pathological descriptions of the eruption, and recent drug intake. Cases were ascertained as de¢nite or
possible AGEP by an international expert committee, based on a scoring system taking into account
morphology of the eruption, course of the disease and histopathology.
We evaluated 150 potential community cases of acute exanthematous pustular eruption. Among
those, 96 cases ful¢lled criteria for AGEP. Mean age of patients was 55.5 y (4-91), with a male/female
sex-ratio of 0.8. Age repartition di¡ers from that of Stevens Johnson syndrome and toxic epidermal
necrolysis. The death rate was 4%. Erythema and pustules were widespread in 89% and 73% of pa-
tients with folds accentuation in 46% and 50% respectively. Recent herpes infection, HIV and other
infections, autoimmune diseases, liver or renal diseases, cancer and X ray therapy, atopy, and psoriasis
were not associated or risk factors.
Based on these prospectively collected data, we con¢rm the reality of this disease, with a speci¢c
clinical pattern and evolution, and with no association to psoriasis.
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Presence of Epstein-Barr Virus in CTCL
AC Knol, MC Pandol¢no,Y. Guilloux and B. Dreno
INSERMU463, Nantes, France
Cutaneous T-cell lymphomas are characterized by an epidermal in¢ltration of T lymphocytes of the
CD2þCD3þCD4þCD45ROþDRþ phenotype. The aetiology of this pathology remains un-
known. Some viruses such as EBV and HTLV-1 have been investigated for years to play a role in this
disease, but the results remain much debated. The aim of our study is to discuss the role of EBV in
CTCL.We observed by immunostaining the presence of the EBNA2 protein in the Langerhans cells
of the epidermis of Sezary patients. This work was realised with samples of patients presenting a Sez-
ary syndrome histologically con¢rmed with more than 50% circulating Sezary cells.We ¢rst realised
cocultures between PBL of these patients and the autologous dendritic cells from blood; this approach
allowed us to seek for EBV-speci¢c T lymphocytes among the PBL of the cocultures.We also looked
for the presence of the virus by immunostaining on FROTTIS of the cocultures. Concurrently, we
investigated the non-sorted and positively Vb cell-sorted PBL, for the presence of mRNA of EBV,
EBER-1 and BZLF-1. So we wondered if it existed an EBV-speci¢c T lymphocyte response towards
the autologous B-EBV cell-line. This response was measured by the intracytoplasmic production of
IL-2.We showed neither a T lymphocytes’ speci¢c IL-2 production towards the autologous B-EBV
cell-line, nor the presence of the virus in the patients’ PBL. These results con¢rm that, in spite of the
presence of EBV in the lesional skin, which we observed by immunostaining, EBVdoes not infect T
lymphocytes of Sezary patients. So it would be of interest to look for EBV-speci¢c T lymphocytes in
the lesional skin, within skin in¢ltrating lymphocytes, and to isolate in vitro the Langerhans cells of
these patients.
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Cored Tubules are Present in Human Epidermal Langerhans Cells and Belong to
the Endosomal Recycling Compartment
D. Lipsker, U. Ziylan, R. McDermott,w D. Spehner, F. Proamer, J.-P. Cazenave,z B. Goud,w H. de
la Salle, J. Salamerow and D. Hanau
INSERM EP 99-08 ‘‘Biologie des Cellules Dendritiques Humaines’’and zINSERMU 311, Etablissement
Franc ais du Sang-Alsace, 67065 Strasbourg Cedex, France; wUMR 144 CNRS-Institut Curie, Laboratoire
‘‘MeŁ canismes MoleŁ culaires duTransport Intracellulaire’’, Institut Curie, 26 rue d’Ulm, 75248 Paris Cedex 05, France
Cored tubules are ultrastructural organelles described to date only in murine cells belonging to the
‘‘Langerhans cell’’ family and located in the dermis and its draining lymph nodes. These organelles, the
function of which is unknown, di¡er from Birbeck granules and are interestingly not found in mur-
ine epidermal Langerhans cells. In this work we demonstrate that cored tubules are present in freshly
isolated human epidermal Langerhans cells. The tubules were found to be interconnected with struc-
tures known to belong to the early endosomal pathway and could be immunolabeled with gold-con-
jugated anti-CD1a monoclonal antibodies, but only at 371C. At this temperature such antibodies are
able to progress from the early sorting endosomes to the early recycling endosomes, which in human
Langerhans cells include the Birbeck granules. These ¢ndings strongly suggest that cored tubules form
part of the early recycling compartment.
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TNF-a Induces the Phenotypical and Functional Maturation of Human Epidermal
Langerhans Cells
O. Berthier-Vergnes, F. Bermond, D. Schmitt, J. PeŁ guet-Navarro
INSERMU 346, HoŒ pital E Herriot. 69437 Lyon 03
TNF-a was reported to promote the maturation of dendritic cells generated in vitro from CD34þ
progenitors or monocytes, but not that of mouse epidermal Langerhans cells (LC). The aim of this
study was to analyse the e¡ects of TNF-a on the phenotypical and functional maturation of human
epidermal LC. To this end, LC were puri¢ed from healthy human skin and incubated for 2 days in a
serum-free medium in the presence or not of TNF-a, before analysing their phenotype and allosti-
mulatory function. Results showed that TNF-a (2.5-50 ng/ml) clearly upregulated expression of
CD40, CD54, CD83, CD86, CCR7, DC-LAMP in a dose-dependent manner, whereas HLA-DR,
CD1a and CD80 remained unchanged.ThisTNF-a-induced phenotypical maturation of LC correlates
with an enhanced allostimulatory capacity. After the 2-day culture in medium alone, two LC subsets
were distinguished: one exhibiting low-size/low HLA-DR/high langerin and the other a high-size/
high HLA-DR high/low langerin. TNF-a signi¢cantly increased the relative number of the latter
LC subset, this e¡ect being due to the protective e¡ect of TNF-a against apoptosis. We also tested
the e¡ect of TNF-a on LC migrating out of cultured epidermal sheets derived from normal skin.
TNF-a enhanced LC emigration, and LC level expression of CD83, CD86, CCR7 when compared
to untreated epidermis. Collectively, our data demonstrate that TNF-a promotes the phenotypical and
functional maturation of human epidermal LC.
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CD1d Expression and Regulation on Langerhans Cells
S. Ronger-Savle; J.Valladeau; C. Dezutter Dambuyant; S. Porcelli; D. Schmitt; A. Claudy; D. Jullien
Inserm U346; Edouard Herriot Hospital; Lyon; Department of microbiology and immunity, AECOM, NewYork
The CD1 family of cell surface glycoproteins is a third lineage of antigen presenting molecules. They
present lipidic, glycolipidic antigen and hydrophobic peptide toT cells. CD1d restricted T cells might
play a role in autoimmune disease and in antitumor immunity. Human CD1d tissular distribution is
not well established. In the present report, we studied CD1d expression on cutaneous professional
antigen presenting cell.
Langerhans-like cells were generated in vitro from cord blood CD34þ stem cells (GM-
CSFþ SCFþTGFbþTNFa; 13 days); from adherent PBMC (GM-CSFþ IL13þTGFbþTNFa; 7
days) and in vivo from cutaneous extraction. Dermal dendrocytes were di¡erentiated from PBMC
(GM-CSFþ IL4; 7 days). Using speci¢c primers, CD1d mRNAwas detected by RT-PCR and cell sur-
face expression by £ow cytometry (mAb CD1d 27.2, 42.1, 51 and 19, S Porcelli, Boston). Immunochem-
istery was performed on normal and pathologic skin specimens (n¼ 8, mAb NOR3.2, Biosourcet).
Double staining immuno£uorescence suggested that both Langerhans cells (CD1aþ ) and dermal
dendritic cells (Factor XIIIaþ ) expressed CD1d. Cell surface expression was not con¢rmed by £ow
cytometry on Langerhans cells and was very low on confocal microscopy. Flow cytometry was posi-
tive on Langerhans cells generated from cord blood CD34þ , but was di¡erent with di¡erent anti-
bodies. TGFb seems to decrease CD1d expression in £ow and RT-PCR on these cells. At least, on
Langerhans cells generated from adherent PBMC, £ow was negative; but not on dermal dendrocytes
obtained from adherent PBMC. Maturation with CD40L increase this expression on these cells on
£ow,Western Blot and PCR.
Our data suggest that CD1d is expressed on dermal dendrocytes and also on Langerhans cells but
with a very low expression. There is a di¡erence between na|«ve cells and cells obtained in vitro.We
can explain this di¡erence because cells obtained in vivo and in vitro are di¡erent and because cuta-
neous extraction could break antigen sites.
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Evaluation of Telomerase Activity on Human Keratinocyte Using a Real-Time
Quantitative Telomeric Repeat Ampli¢cation Protocol Assay
Bonnet-Duquennoy M., Lazou, K., Cousin, C., BonteŁ , F., Schnebert, S., MaheŁ , C. and Kurfˇrst, R.
GIE LVMH Recherche, 45804 Saint Jean de Braye, France
Telomerase is a ribonucleoprotein enzyme that directs synthesis of telomere. Telomerase activity is
present in normal human somatic and in a majority of immortal and cancer cells. Ectopic expression
of telomerase has been shown to extend the life span of several normal human cells. These observa-
tions have led to a hypothesis that telomere length may function as a ‘‘mitotic clock’’ to sense cell
ageing, signal replicative senescence or programmed cell death. Telomeric repeat ampli¢cation proto-
col (TRAP) is widely used for detection of telomerase activity. This method includes a PCR step
detection which does not provide precise quanti¢cation. The aim of our study is to develop a quanti-
tative TRAP assay by combining a real-time PCR measured with light cycler and classical TRAP
method. Using dilution series of protein extracts from HaCaT, a keratinocytes cell line, we showed
that our method is linear, speci¢c, sensitive, rapid and reproducible.With this assay, telomerase activity
could be determined on NHK (normal human keratinocyte) and e¡ect of UV-B was studied. We
showed a transient increase of telomerase activity after 100 mJ/cm2 UV-B irradiation. On the other
hand, immediately after low dose, no di¡erence was observed whereas 24 hours after stress, inhibition
of activity was showed. Addition of real time quanti¢cation PCR step on classical TRAP assay per-
mitted a rapid, reproducible and precise quanti¢cation of telomerase activity to improve comprehen-
sion of regulation of this important cellular enzyme.
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Fractalkine: a Chemokine Target for a Skin Anti-in£ammatory Therapy
Crola C.2, Lecle' re S.3, Marteau C.1, Mitterrand M.2, Schnebert S.1, MaheŁ C.
1, AndreŁ P.
1, Franchi J.1,
Kieda C.2
1Laboratoires de Recherche et DeŁ veloppement, LVMH Branche Parfums et CosmeŁ tiques, Saint Jean de Braye, France
2Centre de Biophysique MoleŁ culaire, UPR 4301CNRS, rue Ch. Sadron, OrleŁ ans, France;
3BioEurope, Groupe
Solabia, Anet, France
The in£ammatory process involves the recruitment of cells which gather at the endothelial wall sur-
face. Recruitment is characteristic of the pathology and speci¢c of the endothelium in an organ and
microenvironment-dependent manner. This means the participation of a cascade of signal/adhesion
molecules which are chronologically distinct but co inducing one another. Among the molecules
which give the speci¢city of the recognition are immunological factors of the chemokine family: re-
gio- and stroma-restricted in their expression, they are presented by endothelial cells to build the che-
motactic gradient. Fractalkine: CX3C chemokine is a keratinocyte product which, as we show here:
^ is UV induced in keratinocytes in situ,
^ binds and activate skin-derived endothelial cells; and
^ enhances the skin endothelial cells adhesion properties.
Fractalkine action was used to test putative pro- or anti-in£ammatory molecules by an in vitro model
using advantageously dermal endothelial skin cells line as compared to other endothelial cell lines,
following leukocyte recruitment by a quantitative adhesion assay. This allowed to assess the activa-
tion/inhibition of adhesion and will be compared to general activators as H2O2 or UVs.
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A New System for Measuring the Mechanical Forces of Collagen Lattices Gener-
ated with TGF-b1
C.Viennet1,T. Saguet1, J. Bride1, F. Elha|«meur1, A-C. Gabiot1,V. Armbruster2,T. Gharbi2,
E. Gentilhomme3, P. Humbert1
1Engineering and Cutaneous Biology Laboratory, School of Medicine, F-25030 Besanc on; 2Optical Laboratory,
School of Science, F-25030 Besanc on; 3CRSSA, F-38702 LaTronche
Introduction: TGF-b1 is considered one of the most ¢brogenic cytokines being implicated in di¡erent
types of lesions. It is well known that TGF-b1 enhances the ability of ¢broblasts to contract a collagen
matrix. Contraction is usually determined by measuring collagen gel diameter.We developed a new
system in this study to measure directly the forces generated byTGF-b1 treated ¢broblasts.
Materials and methods: Rectangular lattices were polymerized between two silicon slides. They were
attached to this sensor through a grid directly etched on the silicon stripe. The slide deformation was
measured by the strain gauge deposited on its surface. Lattices (n¼ 8) were cultured over a 12-day
period and were treated with 2.5 ng/ml of TGF-b1 at days 0, 4 and 8.
Results: The forces were permanently higher than those of the control lattices. The di¡erence in-
creased with the culture time, from 23% at day 1 to 51% at day 9.
Conclusion: TGF-b1 could increase the contraction force of the lattice. In measuring the contraction
forces, our system was proved to be more precise than the variation of the contraction diameters. It is
auxillary to study the e¡ects of the pharmacological agents on the mechanical properties of the dermal
equivalents.
P31
Multi-Agents Computer Simulation: Towards a New Way of Research in Allergy
and Immunodermatology?
G. Desmeulles, D. DupreŁ
,V. Rodin, L. Misery
Ecole Nationale d’IngeŁ nieurs de Brest/Laboratoire IngeŁ nierie Informatique;
Service de Dermatologie du
Laboratoire de Neurobiologie CutaneŁ e du CHU de Brest
The object of our study is to supply to the researchers in allergology and immunodermatology a
technical platform of computer simulations using the multi-agents approach (individual-based ap-
proach) in order to develop an in virtuo experimentation laboratory of biological processes. The
adopted computer approach proposes to model a biological system thanks to the concepts of agent
(individual : cell), environment, interaction, organization and user (biologist). A computer agent is
an autonomous entity able perpetually to perceive its immediate environment, to decide which action
to realize and ¢nally to achieve this action acting on its environment.
We progress in the development of a multi-agents model of the allergic reaction, allowing to con-
sider simple in virtuo experiments. This kind of modeling has the advantage of allowing a simple de-
scription of more or less complex interactions between cells.We will now speak of agent-cell. Several
types of agent-cells (Lymphocytes B,T,y) can thus be modelled within a multi-agent system mod-
elling an immunological reaction. As for them, the interactions can be modelled through the ex-
change of messages between agents. These messages can be assimilated to the exchange of chemical
messengers (Interleukines, Interferonsy) between cells.
We will present the ¢rst results obtained thanks to a multi-agent simulation engine using SBML
(Systems Biology Markup Language). SBML is a standardized description language allowing a non-
data processing specialist to simply describe biochemical reactions. The presented simulations results
will concern the binding between histamine and its receptor.
The interest of this approach is either to test hypotheses (e.g., which is the action of a new molecule
on a reaction?) or to work on pathologies for which there is no in vivo animal model or in vitro model
thus working on an in virtuo computer model.
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Signi¢cant Association of Polymorphism GLN27 GLU OF 2-Adrenergic Recep-
tor and Psoriasis
Roguedas AM1,2, Audrezet MP2, DupreŁ D
1,2, Scotet V2, Ferec C2, Misery L1
1Service de dermatologie, 2INSERM-EMI 0115, Laboratoire de GeŁ neŁ tique MoleŁ culaire, CHUMorvan, Brest
Stress is the most frequent triggering factor of psoriasis. Stress induces the release of catecholamines,
which have a high a⁄nity for 2 adrenergic receptors. 2 adrenergic receptors are expressed on Lan-
gerhans cells, keratinocytes and lymphocytes, which are cells involved in the pathophysiogeny of psor-
iasis. Four polymorphisms (located in 16, 27, 34 et 164) are responsible for modi¢cations of the
functioning of these receptors.We have searched for a possible association of polymorphism 16 and
27 of this receptor gene with psoriasis.
Our study has been performed in 56 patients su¡ering from psoriasis. After DNA extraction, the
genotyping was done by PCR and direct sequencing of candidate genes. Statistical analysis was rea-
lised with Epi-Info 6 04 for w2 test.
We did not reveal any di¡erence of the Gly16Arg with normal Caucasian subjects. But our data
supported an signi¢cant association of the Gln27Glu with psoriasis (p¼ 0.0026) with an odd-ratio of
0.41(0.22^0.77).
This polymorphism is known to induce a downregulation of receptor expression. In patients with
psoriasis, the e¡ects of catecholamines are probably decreased, whereas they are able to modulate acti-
vation of T cells and induce di¡erentiation of keratinocytes. Hence, the presence of this polymorph-
ism might be implicated in the pathophysiogeny of psoriasis.
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ATri-Compartmentalized Co-Culture of Keratinocytes, Neurons and Glial Cells
Yannick Chateau, Germaine Dorange, Nathalie Rougier, Laurent Misery
Laboratoire de Neurobiologie CutaneŁ e, Institut de Synergie des Sciences et de la SanteŁ, Brest
Our aim was to perform a co-culture of keratinocytes and neurons in order to study their relation-
ships.
In this purpose, we used a three compartmentalized box with separated domains. In the ¢rst part of
this box, we put a cellular suspension of keratinocytes (4 million cells/ml) obtained from biopsies of
human skin. The central domain was sowed with sensorial neurons from the dorsal root ganglion of
rats. The last territory was occupied by neurons from the dorsal horn of bone marrow (sensitive part).
All types of cells were obtained by enzymatic and after mechanic dissociation. Sensorial neurons grew
in low density (500 cells), method which needs a glial feeder layer obtained by a sub-culture of spinal
cord cells, and a conditioned medium from astrocytes. After 15 days of culture, cells were ¢xed and
stained by immunochemistry directed against PGP 9.5 (neurons), keratins, and nucleus with propi-
dium iodide. Boxes were observed by confocal microscopy.
In this way, we obtained a co-culture with three identi¢able territories. Keratinocytes were orga-
nized in groups of about ¢fty cells. Neurons were organized in several groups of cells related by a
dense network of nervous ¢bers, which allowed an easy recognition from keŁ ratinocytes. In the spinal
cord equivalent, only a few cells were observed. Nervous ¢bers which came from the neuronal terri-
tory speci¢cally headed from groups of keratinocytes to other groups of keratinocytes. Other nerve
¢bers were directed towards the spinal cord equivalent.
This model allows us to reconstruct in vitro an equivalent of sensitive nerve ¢bers, connected for
one part to a spinal cord equivalent and on the other part to an epidermal equivalent. Such a model
can be used to study the interactions between keŁ ratinocytes and nerve ¢bers.
P34
An In Vivo Inducible Murine Melanoma Model for the Study of the Antitumoral
Immune Response
Fabrice Lema|“ tre, L. Chin, M. Brown, M.Viguier, P. Kourilsky and L. Ferradini
INSERMU277, Pasteur Institute, Paris, France
Malignant melanoma is considered as a model of an immunogenic tumor in man because of the ex-
istence of spontaneous tumor regressions, the identi¢cation of tumor antigens speci¢cally recognized
by cytotoxic T lymphocytes and because of a positive correlation between the presence of some lym-
phocytic in¢ltrates with patient survival. However, the presence of a clinically detectable tumor in and
of itself outlines the ine⁄ciency of the immune control. Results of the ¢rst immunotherapeutic clin-
ical trials in human melanoma patients are encouraging but remain limited, suggesting that the stra-
tegies being tested are not the most appropriate. Beside empirical approaches, elaborating new e⁄cient
immunotherapeutic strategies will need to have a clear idea about the functioning antitumoral im-
mune response in man and/or to study animal models more related to situations encountered in the
clinic. In order to study the mechanisms involved in immunosurveillance against melanoma and the
role played by the tumoral microenvironment, we are developing an inducible murine model of mel-
anoma in vivo.We are adapting a recently described inducible melanoma model based on the melano-
cyte speci¢c inducible expression of the H-Ras activated oncogen (H-Ras V12) using the tyrosinase
promoter and the Tet-on system. Such H-Ras V12 expression in melanocytes of p16Ink4a/p19Arf KO
mice induces melanoma in 35% of the animals following 1-2 months of doxycyclin treatment. After
early UV treatment, almost 60% of the mice developed a melanoma. In order to study the adaptive
antitumoral immune response, we have introduced an inducible model tumor antigen, the LCMV
glycoprotein, through transgenesis. Finally, this in vivomodel developed here should be suitable to test
new strategies of immunointerventions which might be more relevant for human melanoma than
mouse transplantable tumor models used until now.
P35
Withdrawn.
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A Pilot Study to Establish Methods for Using Gene Expression Pro¢ling Maps to
Identify Patients with Melanoma Risk
JeŁ roŒ me Barge, Benoit Bon, Marie-Aleth Richard, Joanna Vitte, Jean^Jacques Grob et Patrick Verrando
LIMP, laboratoire d’Investigation des Maladies de la Peau (EA3291), Univ. De la MeŁ diterraneŁ e, Marseille ^ France
We are trying to apply for the ¢rst time a genomic approach to prediction of melanoma (MM) risk.
The goal is to know if it is possible to establish objectively (mathematically) predictive gene expres-
sion maps (GEM) for melanoma risk, based on gene information harbored by nevi. Nevus phenotype
is considered to be, with solar exposure, a risk marker for MM. In this preliminary pilot study, we
evaluated the bio-informatics tools and the conditions required to access predictive GEM for MM.
Among genes modulated by a UV-B stress in normal human melanocytes, as revealed by our mi-
croarray analysis (ValeŁ ry et al. J Invest dermatol 2001), we selected 10 genes that ¢tted some a priori
criterions. Their expression was monitored by quantitative RT-PCR in nevus biopsies (34 samples)
from patient groups with risk of MM. Expression levels were normalized to the mean or to the med-
ian of data for each gene. These data were then processed through di¡erent bioinformatic analyses to
obtain GEM: Hierarchical cluster analysis, non-hierarchical cluster analysis (K-means), principal com-
ponent analysis (PCA), using either Euclidian metric distance (ED) or Pearson’s coe⁄cient (PC). Re-
sults showed that normalization using data mean or data median did not change GEM a lot, while ED
and PC did. The presence or absence of a gene linked to sex patient (DEAD H BoxY polypeptide)
modi¢ed in a large extent results of the cluster analyses.When the gene was considered, 14/20 (70%)
of men that bore the so-called atypical nevus syndrome (ANS) were discriminated in two clusters, a
third one homing only male patients without ANS. Only 8/14 (57%) of women bore ANS, and they
were clusterized in another group.When the sex-linked gene was not considered, 4 to 5 clusters were
observed, whatever the AC method employed. A stronger robustness was found for 2-3 of these clus-
ters. However, in the present state of the study, it is di⁄cult to decipher the clinical-epidemiological
relevance of these clusters. The data suggest that it might be that cases with recurrent nature of MM
fall in only one cluster. GEM suggests also that 2 nevi from di¡erent locations in the same patient
were usually (60%) phenotypically similar.
This preliminary study points out the usefulness of cluster analyses and GEM to better characterize
nevus phenotypes and their relationships with MM risk. It also shows the di⁄culty of interpreting the
results and linking them with clinical parameters. Increasing gene and patient numbers without any
a priori choice seems to be necessary to make these studies truly informative, and calls for the help of
microarray technology.
P37
Regulation of Type I and III Collagens Expression in Fibroblasts
Kypriotou M., Chadjichristos C., ReŁ nard E., Pujol J.-P., and GaleŁ ra P.
Laboratory of connective tissu biochemistry, Faculty of Medicine, lev. 3, 14032 Caen Cedex, France
Type I and III collagens, two phenotypic markers of the dermis, display an increased expression dur-
ing ¢brotic reactions. To better understand the molecular mechanisms involved in ¢brosis, we ¢rstly
investigated the e¡ect of Sp1, Sp3 and NF-kB transcription factors (p50 and p65 subunits) on the
expression of both of collagen isotypes.
To this aim, expression vectors, in which were cloned the cDNA encoding these transcription fac-
tors, were transiently transfected in young children foreskin ¢broblasts. Newly synthesized collagen
production was estimated by bacterial collagenase assays and COL1A1 and COL3A1mRNAs expres-
sion level by real time RT-PCR analysis.
The resullts obtained showed that Sp1 inhibits collagen neosynthesis, as well as p50 and p65,
whereas Sp3 exerts an activating e¡ect. Sp3, p50 and p65 exert a transcriptional control as the e¡ects
observed on COL1A1 and COL3A1 mRNAs level are correlated with collagen protein expression.
However, Sp1 does not modify COL1A1 and COL3A1 mRNAs expression.
We can therefore conclude that there is a correlation in the expression of type I and III collagens in
¢broblasts. Moreover, Sp3 and NF-kB exert a transcriptional control on both collagen isotypes ex-
pression whereas Sp1 is responsible for a post-transcriptional regulation. Overall, these data suggest
that these transcription factors are implicated in an coordinated regulation of type I and III collagens,
and maybe therefore involved in ¢brotic diseases.
C1
Epidermal Extracellular Matrix: NewArguments for an Emerging Idea
Duhieu S, Laperdrix C, Boukerche H, Ishikawa K, Sommer P, Schmitt D, Haftek M
Unit 346 INSERM/CNRS, E. Herriot Hospital, U. 590 INSERM, CLB, CNRS-UMR 5086, IBCP,
Lyon, France and Shizuoka University, Japan
The extracellular matrix produced by dermal cells is able to control, in turn, several important
biological processes: proliferation/apoptosis, cell segregation, polarisation, di¡erentiation, adherence/
migration.
The extracellular spaces of human epidermis also contain a few types of matrix-like molecules
(e.g., ¢bronectin, tropoelastin, syndecan-1, collagen XIII) and enzymes (extracellular trans-glutami-
nase, lysyl oxidases), what suggests the existence of the epidermal extracellular matrix. In our search
for new elements present in the interkeratinocyte spaces, we have used three not yet fully characterised
monoclonal antibodies staining this tissue compartment: KM48, 7C1 and Ly1. The biochemical pro¢le
of the corresponding antigens indicates that these molecules belong to the proteoglycan family. Im-
munocytochemical studies of normal human epidermis were performed on skin biopsies (ultracryo-
sections and Lowicryl K11M) and on epidermal cell suspensions (£ow cyto£uorimetry and
immunogold labelling), including the comparison with antibodies to syndecan-1 and CD44, known
keratinocyte surface proteoglycans. Our three antibodies show the extracellular pattern of labelling
limited to the epidermis. The labelling intensity varies according to the degree of keratinocyte di¡er-
entiation. Additionally, KM48 antibody reacts with dissociated desmosomes, whereas Ly1 detects the
antigen present in these junctions in situ. Hemidesmosomes remain always unstained but the persis-
tence of some antigens in the corneodesmosomes could be detected.
Provided the important role performed by proteoglycans in cellular interactions, ¢ltration and
retention of growth factors and other soluble molecules, the presence of these elements in the inter-
keratinocyte spaces opens up new avenues in the research on functions of the extracellular epidermal
matrix.
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Mucosal Tight Junctions: Occludin, Claudin-1 and ZO-1 are Similarly Expressed in
InVivoVaginal Mucosa and in InVitro Pluristrati¢ed Reconstructions
Go¥o S., MareŁ chal S.,Valladeau J., Dumont S., Bouschbacher M., Bechetoille N., Schmitt D.,
Dezutter-Dambuyant C.
INSERMUnit 346, Edouard Herriot Hospital, Lyon, France
Epithelial cells from a simple epithelium form ¢ve distinct types of junctions between neighbouring
cells and the underlying basal membrane: tight junctions, adherens junctions, desmosomes, gap junc-
tions, and hemidesmosomes. Tight junctions (TJs) are located at the most apical part of the lateral
membrane of epithelial and endothelial cells and are implicated in multiple functions such as the bar-
rier and signalling functions. TheTJ forms a regulated, semi-permeable barrier preventing solutes and
water from passing freely through the paracellular pathway. Each TJ comprises three transmembrane
proteins: occludin, claudins and JAM, while ZO-1, member of a MAGUK protein family, is found in
cytoplasmic plaques. The TJ proteins are connected to actin cytoskeleton. TJs have been identi¢ed by
transmission electron microscopy while TJ antigens, by immunolabeling in simple epithelium and,
more recently in adult (in the granular cell layer) and developing human epidermis. In our study,
the expression of occludin, claudin-1 and ZO-1 was elucidated in normal vaginal epithelia by light
immuno-labeling and compared to the E-cadherin expression. Furthermore, the existence of TJ-like
structures was investigated by transmission electron microscopy in normal vagina and in recon-
structed pluristrati¢ed buccal and vaginal epithelia maintained in immerged or emerged culture con-
ditions. Finally, the tightness of the barrier of the reconstructed epithelia was investigated by
measuring the transepithelial electrical resistance (TEER). Occludin and claudin-1 that are thought
to be more speci¢c for JTs are largely distributed all over the various layers of the epithelia with a
marked degree of co-localization to the E-cadherin, speci¢c of the adherens junctions. The location
of ZO-1was detected from the uppermost suprabasal cell layers up to the apical border of the epithe-
lia. A similar pattern was found on reconstructed buccal and vaginal epithelia. Transmission electron
microscopy showed that TJs close to the apical surface of the epithelial reconstruction were better
visualized in immerged culture conditions than in emerged ones. The TEER value (33 ohm/cm2)
was closed to a monolayer of intestinal epithelium. The wide distribution of TJs in in situ and recon-
structed pluristrati¢ed epithelia suggests that TJs convert the vaginal epithelia into a better barrier to
water loss and environmental pathogen attack than it could have been previously thought.
C3
Comparative Expression of Vascular Endothelial Growth Factor Family Members,
VEGF- B, C and D, by Normal Human Keratinocytes and Fibroblasts
Trompezinski S, Berthier-Vergnes O, Denis A, Schmitt D,Viac J.
INSERMU 346, Clinique Dermatologique, HoŒ pital E. Herriot, 69437 Lyon;
SocieŁ teŁ Bioderma, 75 Cours Albert
Thomas, 69003 Lyon, France
The vascular endothelial growth factor (VEGF) family includes the related polypeptides VEGF-B,
VEGF-C,VEGF-D, which contribute to endothelial and lymphatic vessel development. The parental
VEGF molecule,VEGF-A, has been widely described in the skin but the other members of theVEGF
family have not yet been reported.
The aim of our study was to determine whether the two main skin cells, keratinocytes and ¢bro-
blasts expressed VEGF-B, VEGF-C and VEGF-D in basal condition and after stimulation by either
growth factors or the pro-in£ammatory cytokine TNFa. RT-PCR analysis on cultured normal hu-
man keratinocytes (NHK) and normal human ¢broblasts (NHF) allowed the detection of di¡erent
levels of VEGF-B,VEGF-C and VEGF-D mRNA in both cell types with similar PCR products in
the skin cells. A semi-quantitative evaluation of the VEGF family proteins by dot blot using the dif-
ferent human recombinant VEGFs showed di¡erent levels of VEGF-B, VEGF-C and VEGF-D in
NHK and NHF. After cell stimulation by growth factors (EGF and TGFb1 for NHK and NHF re-
spectively), a signi¢cant up-regulation of the VEGF family member proteins was observed in NHF
but not in NHK. Conversely,TNFa did not exert a signi¢cant e¡ect. However, we could not detect
any transcriptional modi¢cation in stimulated cells whatever the stimulation duration.The addition of
cycloheximide to the cell cultures strongly inhibited the increase of VEGF proteins in TGFb1-stimu-
lated NHF. Taken together the results underline the major role played by NHF in the elaboration of
theVEGF family proteins known to regulate wound healing, chronic in£ammation and tumor angio-
genesis and lymphangiogenesis.
C4
Distinct Roles for Jun-N-Terminal Kinase and NF-jB in the Regulation of a(2)Type
I Collagen Gene (COL1A2) Gene Expression byTumor Necrosis Factor-a
Franck Verrecchia et Alain Mauviel
INSERMU532, Skin Research Institute, Saint-Louis Hospital, Paris, France
Given the physiological importance of TGF-b and TNF-a, we have investigated the signaling events
underlying the antagonistic activity of tumor necrosis factor-a (TNF-a) against transforming growth
factor-b (TGF-b)-induced a(2) type I collagen gene (COL1A2) promoter transactivation. Transient
transfection experiments using human dermal ¢broblasts showed that expression of a dominant nega-
tive mutant form of MAP kinase kinase 4 (MKK4), blocking Jun N-terminal kinase (JNK) activation,
prevented the antagonistic e¡ect of TNF-a against TGF-b, whereas overexpression of a dominant-
negative form of I-kB kinase-a (IKK-b, preventing NF-kB activation byTNF-a, did not. Next, using
JNK1-JNK2 double knockout (JNK/) and IKK-g/NF-kB Essential Modulator/ (NEMO/) ¢-
broblasts, in which the extent of COL1A2 promoter transactivation by TGF-b is comparable to that
observed in wild-type ¢broblasts, we examined the speci¢c roles played by the Jun N-terminal kinase
(JNK)/AP-1 and NF-kB/Rel pathways in mediating TNF-a inhibitory activity. In a cellular context
devoid of JNK activity (i.e., JNK/ ¢broblasts), exogenous TNF-a did not inhibit Smad-driven
COL1A2 promoter transactivation induced by TGF-b, unless jnk1was re-introduced ectopically. On
the other hand, in NEMO/ ¢broblasts, the absence of NF-kB activity did not a¡ect the antagonistic
activity of TNF-a against TGF-b but prevented repression of basal COL1A2 promoter activity by
TNF-a. Cytokine modulation of endogenous type I collagen expression followed that of the trans-
fected promoter reporter constructs, as estimated both at the protein and mRNA levels. These results
provide de¢nitive evidence for a critical role of JNK activation, and resulting phosphorylation of c-
Jun, in mediating the antagonistic e¡ect of TNF-a on the upregulation of type I collagen gene ex-
pression byTGF-b, whereas NF-kB mediates the direct e¡ect of TNF-a on basal COL1A2 expression.
C5
Biochemical Evidence for the Involvement of Two Kallikreins in Desquamation,
SCTE/KLK5 and SCCE/KLK7
C. Caubet, M. Simon, M. Guerrin, N. Jonca,T. Egelrud1, D. Bernardd, R. Schmidtd and G. Serre
CNRS FRE 2623,Toulouse, France; 1Department of Dermatology, University Hospital, Ume, Sweden;
dL’OREAL, Life Science Research, Clichy, France
Corneodesmosin (CDSN), desmoglein1 (Dsg1) and desmocollin1 (Dsc1) are adhesive proteins of the
extracellular part of corneodesmosomes. Their degradation at the epidermis surface is necessary for
desquamation. Two serine proteases of the kallikrein family, both synthesized as inactive precursors,
have been suggested to participate in this process: the stratum corneum chymotryptic enzyme (SCCE/
KLK7) and the stratum corneum tryptic enzyme (SCTE/KLK5).
The capacity of these enzymes to cleave Dsg1, Dsc1 and epidermal or recombinant forms of CDSN
was analyzed. At an acidic pH of 5.6 close to the physiological conditions of the stratum corneum,
SCCE directly cleaved CDSN and Dsc1 but was unable to degrade Dsg1. Incubation with SCTE was
shown to induce the degradation of the three corneodesmosomal components. Using the recombinant
form of CDSN, either glycosylated or enzymatically deglycosylated, we also demonstrated that oligo-
saccharide residues do not protect CDSN against proteolysis by SCCE. Moreover, our results indicate
that SCTE is able to activate the proform of SCCE.
These results strongly support the involvement of the two kalikreins in desquamation. A model of
a protease cascade, precisely modulated by protease-antiprotease balances, controlling desquamation is
proposed.
C6
The Human Cytomegalovirus-Encoded Chemokine Receptor US28 Constitutively
Induces Caspase-Dependent Pro-Apoptotic Signaling
O. Plesko¡, L.Verneuil, P. Casarosa#, G. Pinon, S. Michelsonw, R. Leurs#, and J. C Ameisen
EMI-U 9922, INSERM/UniversiteŁ Paris 7, IFR 02, AP-HP, HoŒ pital Bichat-Claude Bernard, 75877 Paris cedex
18, France;#Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Chemistry,
Amsterdam, the Netherlands; wUniteŁ d’ImmunologieVirale, Institut Pasteur, 75724 Paris cedex 15, France
Viral subversion of apoptosis regulation plays an important role in the outcome of host/virus interac-
tions. Although human cytomegalovirus (HCMV) encodes several immediate early (IE) anti-apopto-
tic proteins (IE1, IE2, UL37x1 and vICA), no pro-apoptotic HCMV protein has been yet identi¢ed.
Here we show that US28, an IE functional HCMV-encoded chemokine receptor that may be in-
volved in both viral dissemination and immune evasion, constitutively induces apoptosis in several
cell types. US28-induced cell death involves caspase-10 and -8 activation, but does not depend on
the engagement of cell surface death receptors of the TNFR/CD95 family. US28 cell death induction
is prevented by co-expression of C-FLIP, a protein that prevents FADD-mediated activation of cas-
pase-10 and ^8. Finally, coexpression of the HCMV anti-apoptotic protein IE1 or UL37x1 prevents
US28-mediated cell death. Current experiments suggest that US28 pro-apoptotic signaling does not
induce the constitutive US28-mediated PLC signaling pathway. Thus, in infected cells, US28 may
function either as a PLC activator and chemokine receptor or as a pro-apoptotic factor, depending
on expression levels of HCMVor cellular anti-apoptotic proteins.
C7
Gangliosides Puri¢ed from Human Melanoma Tumors Alter the Phenotypic and
Functional Di¡erentiation of Monocyte-Derived Dendritic Cells and Induce their
Apoptosis
J. PeŁ guet-Navarro, M. Sportouch, O. Berthier-Vergnes, D. Schmitt, J. Portoukalian
INSERMU 346, Pavillon R, HoŒ pital E. Herriot, Lyon
Gangliosides, ubiquitous membrane-associated glycosphingolipids, display altered structure in tumor
cells. Moreover, contrary to normal cells, most tumor cells shed large amounts of gangliosides into the
microenvironment and many studies have unravelled their immunosuppressive properties. In the pre-
sent study, we analyzed the e¡ects of GM3 and GD3 gangliosides, puri¢ed from human melanoma
tumors, on the di¡erentiation of monocyte-derived dendritic cells (MoDC). At concentrations close
to those detected in the sera from melanoma patients, both GM3 and GD3 gangliosides dose-depen-
dently inhibit the phenotypic and functional di¡erentiation of MoDC, as assessed by a strong down-
regulation of CD1a, CD54, CD80 and CD40 antigens and impaired allostimulatory function at day 6
of culture. Gangliosides increase prostaglandin E2 production by the MoDC. Furthermore, GM3 and
GD3 gangliosides decreased the viable cell yield and induced signi¢cant DC apoptosis, as assessed by
AnnexinV/propidium iodide and Hoechst staining. Finally, addition of GD3 to di¡erentiating DC
impaired their subsequent maturation induced by CD154. The resulting DC produced low amounts
of IL-12 and large amounts of IL-10, a cytokine pattern that might hamper an e⁄cient anti-tumor
immune response. In conclusion, the results demonstrate that gangliosides impair the phenotypic
and functional di¡erentiation of MoDC and induce their apoptosis, which may be an additional me-
chanism of human melanoma escape.
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PPARS and Cutaneous In£ammation
Brenuchon, C1. Capron, M2. Delaporte, E1. Dombrowicz, D2
1Clinique de Dermatologie - CHRU-59037 Lille Cedex; 2INSERM 547 - Institut Pasteur ^ 59000 Lille
Peroxisomes proliferator-activated receptors (PPARs), are present under three isoforms a, b/d and g.
They belong to the family of nuclear receptors and are known for their role in lipid metabolism and
glucose homeostasis. Several in vitro and in vivo studies have demonstrated their anti-in£ammatory
properties. Knowing that these receptors are expressed by keratinocytes and many in£ammatory cells,
we studied their regulatory activity on skin in£ammation.
Two murine models of in£ammatory dermatoses were selected, atopic dermatitis (AD) and contact
hypersensitivity (CHS), characterized by a type 2 and type 1 cytokine pro¢le. PPARs agonists
(WY14,643 for PPAR-a, carbaprostacycline for PPAR-, ciglitazone and rosiglitazone for PPAR-g)
were topically applied during antigen sensitization of Balb/c and PPAR-a-de¢cient mice.
Histological and immuno-histochemical studies revealed that PPAR-a and -d activation lead to a
reduction in skin thickening and to a decreased recruitment of the e¡ector in£ammatory cells in both
AD and CHS, while PPAR-g agonists did not have any e¡ect in our AD model. ELISA measurements
demonstrated an inhibition of pro-in£ammatory cytokines production and a stimulation of IL-10, an
immunosuppressive cytokine production. Serum IgE concentrations and bronchial hyper-reactivity
occurring upon atopic dermatitis development were also decreased.
Thus, PPARs activation induces a negative regulation of skin in£ammation, characterized by a re-
duction of the sensitization process, hence a decreased systemic response accompanying the develop-
ment of atopic dermatis. Carbaprostacycline was the most e¡ective agonist. It should be noted that
PPARs expression in skin is not constitutive but depends on the in£ammatory status and polarization
pro¢le observed in our two experimental models. A better understanding of the molecular action
mechanisms of these receptors will enable us to consider their use with therapeutic aiming in the
in£ammatory dermatoses.
C9
Expression of 3 Cytotoxic Pathways in Cutaneous Lesions From Reactive and An-
ergic Leprosy Patients
B. Flageul1, A. Soulie2, P. Miailhes2, M. Oster1, M. Sasportes2, L. Dubertret1, P.H. Lagrange3,
A.Wargnier3
1Department of Dermatology; 2Department of Bacteriology; 3UniteŁ INSERMU 462, HoŒ pital Saint-Louis, Paris,
France
We have studied, in cutaneous lesions from di¡erent forms of leprosy, the expression of three cyto-
toxic pathways essential in cellular-mediated cytotoxic immune mechanisms (CMC). In vitro, the po-
tential role of CMC in the development of an e¡ective response to human mycobacterial infection has
been suggested by the obtention from blood or skin lesion of a¡ected or normal patients of BCG or
M.tuberculosis orM.leprae speci¢c cytotoxicT lymphocytes (CD8þ , CD4þ , CD4-CD8-) able to lyse
infected target cells by the cytotoxic granules-associated molecules pathway or the by Fas/FasL path-
way. Otherwise,TNFa and its receptor TNFR1 have been shown to play a crucial role in the epitheŁ -
lioid granuloma formation, a major event in the development of an e¡ective anti-mycobacterial (BCG,
M.tuberculosis) host response.
7 untreated tuberculoids, 5 untreated lepromatous and 7 patients with reversal reaction have been
included. Immunohistochemistry and confocal laser microscopy analysis were performed to study the
expression of perforin, granzyme B and TIA1 (cytotoxic granules-associated molecules pathway) of
CD95 and CD95L (Fas/FasL pathway), of CD120a (TNFR1), CD120b (TNFR2) and TNFa. The three
pathways were found in the 3 groups of patients. However we observed that 1) the Fas/FasL pathway
was predominantly expressed in anergic lepromatous and in reversal in¢ltrates suggesting its minor
role in anti-M.leprae cytotoxic mechanism and in the development of an epithelioid granuloma and
2) the TNFR1was more expressed in reactive forms (tuberculoid and reversal reaction). This ¢nding
enhances the observation in vitro of the major role of the TNFa/TNFR1 interaction in the bactericidal
granuloma formation. Analysis of the cytotoxic granules-associated molecules pathway showed that in
contrast with granulysin, the presence of perforin, GrB and TIA1was not correlated with the level of
anti-M.leprae immune host response. Otherwise, these cytotoxic molecules were found to be ex-
pressed by CD8þ T cells and also by CD4þ T cells (cdþ cytotoxic) and by macrophages.
C10
Study of Constitutive Expression, Cytokinic Modulation and Functional Capacity
of Toll-like Receptors (TLRs) in Normal Human Epidermis
E. Begon, L. Michel, B. Flageul, F. Jean-Louis, I. Beaudoin, H. Bachelez, Ph. Musette
INSERMU532, Institut de Recherche sur la Peau, HoŒ pital Saint-Louis, PARIS.
Recent data gave evidence that Toll-like receptors (TLRs) play a key role in both innate and adaptive
immune responses. The human skin is always exposed to a large number of exogenous stimuli and can
exhibit bactericidal capacities. The aim of the present work was to demonstrate the expression of
TLRs in human epidermis, to study its modulation by proin£ammatory cytokines and to characterize
the function of these receptors within the epidermis.
Primary cultures of basal keratinocytes were established from normal skin biopsies and cultured in
Green’s medium with speci¢c growth factors. Epithelial cell lines (NCTC 2544 and Hacat) were also
included in the study. The basal expression of TLRwas analysed by semi-quantitative RT-PCR, im-
muno-blot, immuno-cytochemistry and £ow cytometry. Modi¢cation in TLR basal expression was
quanti¢ed after cell exposure to various concentrations (1 - 1000 U/ml) of cytokines (IFNg, TNFa)
during 24 to 72h. TLR function was studied in the presence of speci¢c stimuli (peptidoglycans :
TLR2, LPS : TLR4) and quanti¢cation of NF-kappa B translocation to the nucleus was measured by
nuclear DNA-binding activity by electrophoretic mobility shift assay (EMSA) or reporter gene ana-
lysis.
Our results demonstrate that human normal keratinocytes could present an intracytoplasmic ex-
pression of TLR2 and TLR4. The histochemical analysis on frozen skin sections con¢rmed the in situ
expression of TLR4 in the cytoplasm of basal keratinocytes and expression of TLR2 in all the layers
of the epidermis. Exposure of keratinocytes to IFNg increased intracytoplasmic expression of TLR4
without a¡ecting ectopic expression, whereas TNFa stimulated a partial translocation of TLR2 to the
cell surface (25%). Activation of keratinocytes by respective ligands of TLR2 and TLR4 lead to the
nuclear translocation of NF-kappa B within 4 and to stimulation of cytokine production (interleukine
8). Thus, our results demonstrate that human normal keratinocytes are able to respond to exogenous
bacterial stimuli through the expression of TLRs.
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Repertoire, Phenotype and Cytokine Secretion Pro¢le of T Lymphocytes in the
Drug Hypersensitivity Syndrome
D. Picard1, S. Jacquot2, I. Dutot2, F. Tron2,T. FreŁ bourg
3, P. Joly1, Ph. Musette1 & le ‘‘groupe toxidermie’’
1Service de Dermatologie - Hopital Charles Nicolle - CHU Rouen; 2UniteŁ Inserm 519;
3Inserm EMI 9906 -
FaculteŁ de MeŁ decine et de Pharmacie - Rouen
The drug hypersensitivity syndrome (DHS) or DRESS (drug reaction with eosinophilia and systemic
symptoms) is a severe toxic reaction associated with visceral manifestations, sometimes leading to
death. Medications involved are mostly antiepileptics. Despite interruption of the responsible medica-
tion, some patients have a prolonged evolution with sometimes relapses, suggesting the persistence of
the abnormal immunological reaction triggered by the medication.This hypothesis is strengthened by
some observations where relapse seems to be associated in 30% of patients with a lymphocyte expan-
sion that can continue for months after recovery.
Materials and methods: 5 patients with DHS and 10 healthy donors were included in our study. CD4þ
and CD8þ T cells were separated from PBMC using negative selection on MACS columns. A lym-
phocyte T repertoire analysis was performed with the immunoscope technique: after a reverse tran-
scription of lymphocytes RNA, cDNAwere ampli¢ed with a PCRusingVb and Cb speci¢c primers.
Run-o¡ reactions were then conducted on these PCR products with a set of £uorescently labelled Cb
primers. Then, length diversity of PCR products was analysed in a polyacrylamide gel with an auto-
matic sequencer. A lymphocyte expansion is ¢gured as a pick in a Vb family in contrast with the
Gaussian distribution of the CDR3 length usually observed. Lymphocyte phenotype (activation mar-
kers: CD25, CD69, CD134, CD45 RO, HLA DR ) and cytokine secretion (IL2, IL5, IFNg,TNF, IL4,
IL8,IL5, IL13 et IL10) were analysed with a £ow cytometer on blood samples collected at D5, D30 and
D90.When immunoscope analysis showed a repertoire bias with an expanded lymphocyte population
within a particular Vb family, a £ow cytometer analysis with anti-Vb antibody was secondary per-
formed to characterize the phenotype and the cytokine secretion pro¢le of the expanded population.
Results: 4 to 5 immunoscope analyses displayed a repertoire bias for CD4þ and CD8þ T lympho-
cytes. For one patient, the expanded population represented 21% of the total number of CD8þ T
lymphocytes. Patient T cells showed higher level of activation markers (CD25, CD69, HLA DR) than
control T cells, mainly in the CD8þ subset. Expression of these markers was decreasing slowly and
continued 3 months after the beginning of the disease. The cytokine pro¢ling on D5 showed that the
CD4þ and CD8þ Tcells subsets contain respectively 29% and 19% of TNF s.ecreting cells, 6% and
20% of IFNg secreting cells, 34% and 14% of IL2 secreting cells, and 0.2% and 0.8% of IL5 secreting
cells. The cytokine production was increasing for CD4þ and CD8þ T lymphocyte populations
until D90.With the analysis of the expanded populations with anti-Vb antibody, we found that these
cells secrete higher levels of IFNg,TNF and IL2 than the expanded population.
Our results are in accordance with a more important activation in the CD8þ T cell population,
and a Th1 orientated CD4þ T cell response. Moreover, speci¢c study of expanded populations con-
¢rms their predominant part in cytokine secretion.
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Drug-speci¢c Cytotoxic Lymphocytes as the Main E¡ectors of Toxic Epidermal
Necrolysis (TEN)
Nassif A., Boumsell L., Moslehi H., Bagot M., Bensussan A., Roujeau J-C
Inserm U 148, HoŒ pital Henri Mondor, CreŁ teil
We previously reported the ¢nding in the lesions of one patient withTEN of T-lymphocytes harbor-
ing markers of classical CTLs and showing without any re-stimulation, a drug-speci¢c cytotoxicity
against autologous cells.We extended our study to a total of 6 patients.
Methods: Blister £uid cells from 6 TEN patients (cotrimoxazole 3, carbamazepine 1, tetrazepam 1, pir-
oxicam 1) were phenotyped by FACS and tested for cytotoxicity by 51Cr release assay on autologous
lymphocytes and keratinocytes in the presence of therapeutic concentrations of the suspect drug.
Results: Blister £uid lymphocytes were predominantly CD8 þ , DRþ , CLAþ , CD56þ with high
intracytoplasmic concentration of granzyme B. In all 6 cases these lymphocytes were cytotoxic after a
non speci¢c activation of their TCR by a CD3 monoclonal antibody. A drug speci¢c cytotoxicity
towards autologous EBV transformed lymphocytes or towards allogeneic cells sharing HLA-class I
was observed in 4/6 cases. In the two patients tested, autologous keratinocytes were also killed. The
lysis was abolished by EGTA, but not by anti-fas/CD95 strongly suggesting perforin/granzyme
mediated apoptosis, without implication of fas.
Conclusion: This short series strongly suggests that a drug-speci¢c ‘‘classical’’ cytotoxicity (MHC class I
restricted, perforin/granzyme mediated) is the main e¡ector mechanism of TEN. These results chal-
lenge some current concepts and support new therapeutic approaches.
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Drugs Involved in Acute Generalized Exanthematous Pustulosis (AGEP). Results
from EuroSCAR Case-Control Study
Sassolas B, Sidoro¡ A, Flahault A, Bouwes Bavinck JN, Halevy S, Roujeau JC
Department of Dermatology CHU BRESTand the EuroSCAR study group
Acute generalized exanthematous pustulosis (AGEP) is a reaction mostly caused by drugs and charac-
terized by the acute occurrence with rapid resolution, of dozens to hundreds of small, pinhead-sized
non-follicular sterile pustules, arising on an edematous erythema often accentuated in the big folds or
widespread.
In a multinational case control study (EuroSCAR) project we could detect 96 patients that ¢t the
criteria of this disease and were classi¢ed as de¢nite or probable cases with the help of a specially
developed scoring system. A thorough history of drug intake and previous diseases was used to deter-
mine the risk for di¡erent drugs for causing AGEP by comparing them with a group of 1009 hospital
controls.
Multivariate relative risks (RR) for drug coalitions and single drugs were calculated adjusting for
age, gender, country and the intake of other drugs with an elevated risk. For the following drugs a
high relative risk for AGEP is probable (95% con¢dence intervals given in brackets):
Ampicillins RR 21.9 (95% CI: 10-47.8), Quinolones RR 22.5 (95% CI: 6.2-82) Macrolide Anti-
bacterial Agents RR 29; (95% CI: 9.6-87.7 ^ 10 cases attributed to Pristinamycin); Diltiazem RR 15.4
(95% CI: 5.4 -44.1); Antimalarial Drugs RR 12 (95% CI: 3.2-45.1). For Sulfonamide Antibacterials and
Terbina¢ne (4 cases vs. 0 controls) the lack of exposed controls does not allow to calculate relative risks
but the lower bound of the 95% con¢dence interval of 7.1 together with the absence of suspect co-
medication strongly suggests an elevated risk for these drugs. Other drugs with low relative risk and
with no risk will be presented. Drugs with a known elevated risk for causing reactions in the Stevens-
Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) spectrum like Allopurinol or Oxicam-
NSAIDs were not risk factors for AGEP.
Conclusion: The spectrum of causative drugs for AGEP di¡ers from that for SJS/TEN. High risk drugs
for AGEP seem to be: pristinamycin, sulfonamide antibacterials, ampicillins, quinolones, terbina¢ne,
diltiazem and (hydroxy)chloroquine.
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P55 Expression (LY1 Monoclonal Antibody) and Prognosis in Primary Cutaneous
Malignant Melanoma
Cairey-Remonay S1, Boukerche H2, Algros MP1, Mauny F3, Balme B4, Laurent R1, Humbert Ph1,
Aubin F1
1Dpt of Dermatology, CHU de Besanc on, 2INSERMU331, Lyon, 3Dpt of Statistics, CHU de Besanc on, 4Dpt of
Dermatology, HoŒ pital de l’Antiquaille, Lyon, France
P55 is a recently identi¢ed cell surface protein whose in situ expression is dramatically increased in the
melanocytic tumors known to have a relatively high risk of metastasizing (Cancer Res, 2000; 60: 5848-
56). To determine the role of p55 in the clinical progression of melanoma, we examined whether its
expression was associated with other known risk factors and patient survival. 72 stage I cutaneous
melanoma diagnosed in 1988-1991 were investigated based on the availability of representative tissues
and adequate clinical follow-up. P55 expression was assessed immunohistochemically by a highly spe-
ci¢c monoclonal antibody LY1 (HB, Inserm U331, Lyon), and the percentage of stained cells was
visually estimated by independent observers. Univariate and multivariate statistical analysis (Kaplan-
Meier method and Cox regression analysis) were performed after a 10-year follow-up. LY1 was ex-
pressed in 32 tumors (45%). The expression of LY1 was signi¢cantly di¡erent between the group of
patients who subsequently developed metastases and the group whose remained disease-free (85% vs
15%, po103). 92% of patients with LY1 positive melanoma died from their tumor during the fol-
low-up period. Four parameters were signi¢cantly associated with a 10-year disease-free survival: LY1
(po103), tumour thickness (po103), localization (po103), and sex (p¼ 0.005). Three of them re-
mained signi¢cant in multivariate analysis: LY1 (relative risk, [RR]¼ 10.15, 95% con¢dence interval
[CI]¼ 2.58 to 45.66), tumour thickness (RR¼ 7.55, 95% CI¼ 2.14 to 26.58) and localization
(RR¼ 3.26, 95% CI¼1.11 to 9.56). Our results con¢rm that p55 expression is associated with a meta-
static phenotype. Furthermore, p55 expression appears thus to be an independent predictor of 10-year
survival for patients with primary cutaneous melanoma; however, larger prospective studies are re-
quired for validation.
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Prognostic Value of Melanocyte Di¡erentiation Antigens and Angiogenic Markers
in Sentinel Nodes from Melanoma Patients Using Real-Time RT-PCR
D.Vitoux, S. Mourah, J. MeŁ dioni, D. KeŁ rob, O.VeŁ rola, M. Baccard, N. Basset-Seguin, M.E. Toubert, C.
Billotey, M. Revol, JM. Servant, L. Dubertret, P. Morel, C. LebbeŁ
Micrometastasis in a SNL are currently detected after serial sectioning and immunohistochemistry
(IHC). The use of molecular staging with RT-PCR detecting messengers coding for di¡erentiation
or tumoral antigens increases sensitivity but lacks speci¢city. Our aim was to quantify melanocyte
di¡erentiation antigens messengers within SNL in order to assess tumor burden and to evaluate the
angiogenesis switch. All patients ful¢lled at least one of the following criteria: Breslow thickness equal
or greater than 1.5 mm, ulceration, regression, Clark index IV or V. After lymphoscintigraphy and
hand held gamma counter, pathological examination was performed according to the ‘‘Club de Can-
ceŁ rologie’’ guidelines. RNA coding for tyrosinase, mart-1, UPA, PAI-1, VEGF and house keeping
genes were assessed using real-time quantitative PCR. Eight out of 53 patients had micrometastasis
detected by histology or immunohistochemistry. The distribution of all markers can be considered
as exponential. For melanocyte di¡erentiation markers, values grew importantly above 14 copies for
tyr and 15 copies for mart1 for 25 % of patients. For angiogenesis markers, values grew exponentially
above 300, 54 and 20 respectively for UPA, PAI1 and VEGF, for about 50% of patients. All the mean
values of the markers per lymph node were signi¢cantly higher for micrometastatic SNL compared to
uninvolved SNL except VEGFA (respectively po104 for tyr and mart, po0.02 for UPA, po0.03 for
PAI1 and p¼ 0.83 for VEGFA). Sensitivity and speci¢city was 73 and 90% for tyr, 73 and 90% for
mart, and 64 and 74% for UPA, 55 and 81% for PAI1 and 45 and 74% for VEGFA, when positivity
stands for histologically demonstrated micrometastasis or relapse. Using univariate analysis, we
showed that factors signi¢cantly associated with DFS were the presence of histologically proven mi-
crometastasis (po0.03) both melanocyte di¡erentiation markers (TYR: po0.02, MART: po0.03),
UPA (po0.03) and VEGF (po0.03). Only positive mart value was associated with OS (po0.02) and
there was a trend for tyrosinase (p¼ 0.07), UPA (p¼ 0.06), andVEGF (p¼ 0.06). In conclusion, di¡er-
entiation and angiogenesis antigens seems to be promising prognostic markers for sentinel node
examination.
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Radiosensitization and Alteration of Invasion Properties Following BRCA1
Inhibition in A375 Melanoma Cell Line
Hesling C.1, D’Incan M.1,2, Pasco S.3, D’Incan C.1, Montboisse J.-C.3, Souteyrand P.2, Madelmont J.-C1,
Veyre A1, BignonY.-J.1
1Molecular Oncology Laboratory/UMR484, 2Dermatology Unit, CHRU, Clermont-Ferrand, 3CNRS FRE 2534,
Reims - France
Aim: Melanoma is highly resistant to ionizing radiations. BRCA1 (BReast Cancer-1) gene is involved
in doubled-strand radiation-induced dammage recognition and reparation. Our aim was to evaluate
the consequence of BRCA1 inhibition on melanoma radioresistance.
Materials and methods: BRCA1was inhibited in two A375 melanoma cell line derived clones transfected
with an anti-BRCA1 ribozyme then following experiments were done before and after irradiation :
survival assays, expression (real-time RT-PCR, western-blot) of metalloproteases-1,-2,-9, and their
inhibitors (KISS1 et TIMP1),VEGF, EGF, FGF,THBS1,2 and zymography assays for metalloproteases
and TIMP1.
Results: A signi¢cant alteration of survival after irradiation was observed in the clones. After BRCA1
expression recovery in the clones, survival was identical as those of parental A375 cells. In the trans-
fected clones, metalloprotease inhibitor gene expression was enhanced after irradiation and MMP-2
and -9 activities (zymography) were strongly reduced. Pro- and anti-angiogenic gene expression and
FGF expression were not modi¢ed after irradiation.
Comments: These data suggest that BRCA1 inhibition could break melanoma radioresistance and could
a¡ect the invasion properties of melanoma cells. Migration assays are in process. Investigation of the
molecular mechanisms involved in this model is ongoing using DNA microarrays.
These results, if con¢rmed on an animal model, could be the basis of an adjuvant treatment by
direct gene therapy of melanoma metastases.
This work was supported by a grant from the French Society fo Investigative Dermatology.
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Increase of MMP-2 Activation and Melanoma Cells Invasion Through the 67 KDA
Elastin Binding Protein Following Contact with Elastin Peptides
Carole Ntayi1;William Hornebeck2; Philippe Bernard1
Dept. of 1Dermatology and 2Biochemistry; faculty of Medicine Reims ^ France
Interactions between elastin-derived peptides and the 67 kDa elastin binding protein (EBP), were
shown to trigger matrix metalloproteinases (MMPs) expression. Here, we examined whether soluble
k-elastin, obtained from alkaline hydrolysis of insoluble elastin, could in£uence the expression of
MMP-1 and MMP-2, and in vitro invasion of human melanoma cell lines. Our results showed that
plating melanoma cells on a k-elastin substrate resulted in an increase of MMP-2 and TIMP-2 levels,
an overprocessing of MT1-MMP, whereas the expression of MMP-1 and integrin avb3 were not al-
tered. As melanoma cells showed a positive immunostaining for EBP, the increase of MMP-2 secre-
tion was reproduced byVGVAPG, a ligand of EBP, and was inhibited by lactose which can dissociate
EBP from the cell surface. Including k-elastin within collagen gels up-regulated MMP-2 but not
MMP-1 activation, associated to a decrease of TIMP-2 levels. As a consequence, melanoma cells inva-
siveness was enhanced by k-elastin, and the implication of MMP-2 in this process was con¢rmed since
exogenous supply either of rec. TIMP-2, or BB-94, a broad-spectrum MMP inhibitor, reduced this
process. Furthermore, the k-elastin-enhanced melanoma cells invasiveness was signi¢cantly prevented
after treatment with a S-Gal antibody which can recognize EBP at the cell surface. Altogether, these
data suggest that elastin and/or elastin derived peptides, could up-regulate MMP-2 activation through
interactions with EBP, thus facilitating melanoma cells invasion into the dermis.
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In situ Elastolysis in Melanoma: Role in Tumoral Invasion
A.L. Labrousse1, A. Durlach2, P. Birembaut2,W. Hornebeck3, P. Bernard1
1Laboratoire de dermatologie, 2Laboratoire d’histologie Pol Bouin, CHU, Reims. 3Laboratoire de biochimie, CNRS
FRE 2534, IFR 53, FaculteŁ de meŁ decine, Reims
Tumoral invasion is accompanied by a tissue remodeling process, involving a proteolysis of extra-cel-
lular matrix (ECM). Among dermal matrix components, elastin has a key role, since elastin derived
peptides can stimulate, in vitro, invasive tumoral behaviour as well as angiogenesis, chemotaxis, pro-
liferation, and proteolytic activity of ¢broblasts and lymphocytes through a 67 kDa elastin receptor
(S-GAL). Series of skin biopsy specimens including 9 melanomas (5 with a Breslow index (BI)o0.45
mm, 4 with a 2.5 oBI o5.2 mm), 6 cutaneous metastasis and 5 nevi, elastic ¢bers (EF) were stained
with orcein and morphologically and quantitatively analysed with an automated image analyser. All
cutaneous lesions were studied by immunochemistry for the expression of S-GAL and the following
metalloproteases, MMP-2, MT1-MMP, MMP-9, MMP-1 and the inhibitor TIMP-2, by tumoral and
stromal cells, with particular interest for the elastases MMP-2 and MMP-9. Analysis of orcein stained
sections showed that EF had almost disappeared, within tumor, while they were more frequently pre-
served within nevi and increased in the nevi depth. In melanoma, a degraded, thin and punctiform
appearance of EF, until their total absence, was observed at the invasive front (IF) of the thicker mel-
anomas, while a ‘‘pushing’’ appearence was noted in cutaneous metastasis. Quantitative study showed
that elastolysis was particularly important in thick melanomas, suggesting its association to a poor
prognosis. Elastolysis was also observed at close contact to ¢broblasts, macrophages at the IF, and
within peritumoral lymphocytic in¢ltrates. S-GAL was expressed by tumoral and stromal cells.
MMP-2 and its activator MT1-MMP were largely coexpressed at the IF of thick melanomas, suggest-
ing MMP-2 activation at the interface tumor-ECM. MMP-9 was expressed by tumoral cells. The
absence of TIMP-2 expression by tumoral cells could correspond to its endocytosis and degradation
during MMP-2 activation process. Stromal ¢broblasts expressed MMP-1, MMP-2 and sometimes
MT1-MMP. Lymphocytes were negatively stained for the studied proteases. In summary, our results
showed that primary melanoma was characterized by elastolysis, releasing fragmented EF and soluble
elastin-derived peptides at the IF, that possibly represents in vivo a way of amplifying tumoral re-
sponse in melanoma, through interaction with S-GAL receptor.
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Melanocortin 1 Receptor (MC1R) Gene Variants Increase the Risk of Melanoma in
France Independently of Clinical Risk Factors and UV Exposure
Sou¢r N1, Matichard E1,Verpillat P2, Descamps V3, Meziani R1, Legroux E3, Burnouf M3, Bertrand G1,
GeŁ rard B
1, Archimbaud A4, Picard C2, Olliveau L4, Basset-Seguin N4, Crickx B3 et Grandchamp B1
1Laboratoire de Biochimie-GeŁ neŁ tique;
2Service de Biostatistiques; 3Service de Dermatologie, HoŒ pital Bichat-Claude
Bernard; 4Service de Dermatologie, HoŒ pital Saint-Louis
Loss-of-function variants of the MC1R gene, a key control of human skin pigmentation, have been
shown to increase the risk of malignant melanoma (MM) in Queensland, the UK and the Nether-
lands. However, the prevalence and role of MC1R variants in genetic predisposition to MM are not
known in the French population, which has a di¡erent ancestry. Therefore, MC1R variants were
searched in 108 patients a¡ected with MM and in 105 subjects without a personal or familial history
of skin cancer. Patients were divided into two categories: those suspected of genetic predisposition to
MM but without INK4a-ARF or Cdk4 germline mutation (79 cases) and those su¡ering from spora-
dic simple melanomas (29 cases). MC1R loss-of-function variants were present in 72% of melanoma
patients versus 34% of control subjects (po0.0001), con¢rming the role of MC1R in genetic predis-
position to MM in the French population. Three frequent variants were signi¢cantly associated with
MM risk: Val60Leu, Arg151Cys, and Arg160Trp (respective Odds Ratios of 3.64 [4-7.19], 6.26 [2.07-
18.97], and 4.73 [1.70-13.18]). The melanoma-dependant-MC1R risk strongly persisted after strati¢ca-
tion on clinical risk factors (skin color and skin type, hair and eye color, solar lentigines, and nevus
count) and strati¢cation on UV exposure parameters. In multiple logistic regression analysis, MC1R
variants appeared as the second MM risk factor (OR¼ 4,22 [1.967-9.076]) after a high nevus count
(OR¼12,92 [4.80-34.73]). Our data show that MC1R loss-of-function variants are a strong and inde-
pendent melanoma-risk-factor in France, and suggest that assessing MC1R status could be useful, in
association with clinical risk factors assessment, for identifying high-risk groups to be targeted for
prevention.
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CDKN2A as a Uveal and Cutaneous Melanoma Susceptibility Gene
C. Kannengiesser, MF Avril, A. Spatz, K. Laud, G. M Lenoir et B. Bressac-de Paillerets
Institut Gustave Roussy,Villejuif, France
Cutaneous and uveal melanomas (CM and UM respectively) are tumours that arise through malig-
nant transformation of neural crest-derived melanocytes. CM develops from skin melanocytes
whereas UM develops from choroid, iris or ciliary body melanocytes. CDKN2A that encode p16INK4A
protein is the main CM predisposing gene. In contrast, genetic factors predisposing to UM are not
clearly de¢ned. MC1R, the melanocortin 1 receptor gene which acts as a low risk CM susceptibility
gene and as a modi¢er of CDKN2A mutations, does not seem to play any major role in UM suscept-
ibility. Three studies on breast cancer families implicated BRCA2 as a possible UM predisposing gene.
A few ‘‘mixed’’ families have been described whose members are a¡ected by either CM or UM, sug-
gesting that a common susceptibility could exist. Absence of CDKN2A germline mutation was de-
monstrated in two studies performed in familial UM and presumably hereditary UM, respectively. In
a very recent study of 385 sporadic UM cases, a CDKN2A germline mutation was detected in one
patient.
In a ‘‘mixed’’ three melanoma cases family, we have studied the gene CDKN2A by denaturating
high performance liquide Chromatography (dHPLC) and sequencing analysis. Immunohistochemical
staining of p16 was performed on the entire para⁄n-embedded enucleated eye of the UM case.
We now report the ¢rst example of a CDKN2A germline mutation detected in a ‘‘mixed’’ family
CMþUM.The proband who developed choro|« dal melanoma at 47 years was found to be a carrier of
a CDKN2A exon 2 germ line mutation, a 199G4A transition resulting in p16INK4A Gly67Ser. His
sister who developed a CM at 46 years was also a carrier. His daughter developed a nodular melanoma
at 32 years but was not available for genetic testing. Immunohistochemistry performed on the UM
tissue block revealed loss of p16 protein staining in tumour cells.
In conclusion, we describe here the ¢rst CDKN2A germline mutation in a ‘‘mixed’’ melanoma-
prone family comprising cases a¡ected by CM and one case a¡ected by UM. We show also that
CDKN2A loss of function is involved in UM pathogenesis. These observations show that CDKN2A
is also a UM susceptibility gene.
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KIR3DL2/p140 and SC5 Are Two Cell Membrane Receptors Characterizing Malig-
nant Sezary Cells: Comparison with TCRVb Clonal Chain Expression
N. Ortonne, C. Gaudez, P. Musette, M. Bagot, A. Bensussan
UniteŁ INSERM U448, HoŒ pital Henri Mondor, CreŁ teil
CD158k/KIR3DL2/p140 is a natural killer cell receptor expressed by Sezary cells. SC5 is a membrane
receptor over-expressed in Sezary cells and in activated T lymphocytes.We compared the expression of
these antigens to the expression of a clonally expressed TCRVb chain in peripheral blood mononuc-
lear cells (PBMC) from patients with Sezary syndrome (SS). The TCRVb chains detected by £ow
cytometry corresponded to the T cell clones found using immunoscope technique.
Six patients were studied. Five had received treatment, including extra-corporel photochemother-
apy and cytapheresis. T cell clones were characterized by ampli¢cation and analysis of the TCRVb
chains using immunoscope technique. Phenotypic study was performed by £ow cytometry analysis.
We investigated by double stainings whether CD158k/KIR3DL2/p140 and SC5 were present in the
population that expressed the clonal TCRVb found by molecular technique.
There was a good correlation between expression of KIR3DL2 and Sezary cell percentage. In 3
cases, the population that expressed the clonal TCRV co-expressed KIR3DL2. In 1 case, we found a
minor population (o5%) expressing the speci¢c clonal TCRVb. This population expressed SC5 but
was negative for KIR3DL2. In the last case, immunoscope analysis found 5 clones. Using £ow cyto-
metry analysis, all 5 TCRVbwere negative using speci¢c monoclonal antibodies, whereas a subset of
PBMC expressed KIR3DL2 and also TCRab.
KIR3DL2 staining allows detection of tumoral Sezary cells in PBMC. In most instances, KIRDL2
expression correlates to the expression of the clonal TCRVb chain found using immunoscope techni-
que. However, immunoscope analysis does not always detect tumoral Sezary cells. In 1 case indeed,
immunoscope analysis only revealed a reactive T cell clone. In another case, the T cell clones found by
molecular technique were not detected in PBMC using FACS analysis. This study suggests that
KIR3DL2 staining remains the most sensitive method to detect Sezary cells in the PBMC of patients
with SS.
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Constitutive Activation of NF-kappaB Confers Resistance to Mitochondrial Drug -
Induced Apoptosis in Human Cutaneous T Cell Lymphoma (CTCL)
A. Sors, F. Jean-Louis, F.Verrechia, L. Dubertret, H. Bachelez, L. Michel
UniteŁ INSERM U532, Institut de Recherche sur la Peau, HoŒ pital Saint-Louis, Paris, France
Resistance to apoptosis induction by chemotherapeutic agents is a major problem in cancer therapy.
The aim of the present study was to investigate molecular mechanisms of resistance to apoptosis in-
duced by arsenic trioxide (As2O3) in cutaneous T^cell lymphoma (CTCL). Since the Nuclear Factor-
kappaB (NF-kB) family of transcription factors has been implicated in promoting survival of various
hematopoietic neoplasms, we analysed the status of NF-kB pathway in CTCL and its putative role in
resistance to As2O3 induced-apoptosis. Nuclear extracts from CTCL cell lines (HUT78, Seax, Myla)
and tumoral cells from 8 patients with SeŁ zary Syndrome were studied for NF-kB nuclear DNA-bind-
ing activity by electrophoretic mobility shift assay (EMSA). The localization of NF-kB proteins was
analysed by immunocytochemistry and confocal microscopy. The expression of cytoplasmic NF-kB
inhibitors (I-kB) and contra-apoptotic molecules of the Bcl-2 family was investigated by immuno-
blotting.
Results demonstrate the presence of active NF-kB complexes (p50/p65) in the nucleus by confocal
microscopy and ligation with kB elements by EMSA. As compared to normal PBMC, Bcl-2 and Bcl-
XLwere overexpressed in CTCL cell-lines and tumoral cells from SS patients, whereas the levels of I^
kB proteins were not or slightly reduced.The e¡ects of NF-kB inhibitors was investigated on As2O3-
induced apoptosis of CTCL cells. Constitutive nuclear translocation of NF-kB was almost totally
reversed by cell treatment with the NF-kB inhibitors (SN50, ALLN, MG132), as shown by EMSA
and cytochemistry. As2O3^induced apoptosis was potentiated by these inhibitors, as shown by £ow
cytometric determination of annexinV/propidium iodide staining and mitochondrial transmembrane
potential alterations, as well as by immunoblot analysis of increased poly(ADP-ribose)polymerase
cleavage. Our results demonstrate that constitutive activation of NF-kB contributes to the CTCL re-
sistance to As2O3-induced apoptosis.
C23
Immuno-Virological Characteristics of Non-HIV Related Kaposi’s Sarcoma (KS):
A Cross Sectional Study
C. Pellet, D. Kerob, A. Dupuy, M. Carmagnat, O.Verola, P. Morel, F. Calvo, C. Rabian, C. LebbeŁ
Ho“ pital Saint Louis, France.
In this cross sectional monocentric study, HHV8 viremia and various immunological parameters were
screened on all consecutive patients su¡ering from non HIV related (KS) attending our institution
from January 1994 to January 2002. The following parameters were recorded: age at enrolment and
at KS diagnosis, histological type, number of lesions, delay since KS diagnosis as well as the presence
of lymphedema, painful lesions, speci¢c treatment for KS. HHV8 quantitative viral load was assessed
using real-time PCR in the presence of an internal probe within orf26 according to conditions pre-
viously published. Flow cytometry analysis was used for lymphocyte immunophenotyping. 81 pa-
tients were included. HHV8 viremia was positive in 42% of patients. The median value of HHV8
viremia restricted to the 34 patients with positive value was 3.48 log (2.01-4.76).We observed a ten-
dency towards decreased values compared to normal individuals for the following: CD3 (absolute
number), CD3/28 (absolute number), CD3/38 (percentage), CD3/8, CD8/28, CD 4/28 (absolute num-
ber), CD4 RA (absolute number) CD19 (absolute number). By contrast we observed a tendency to-
wards increased values for CD3/25 (percentage), CD3/DR(percentage), CD8/11b (percentage), CD4/
RO (percentage), NK (both absolute number and percentage), NKT (absolute number), IL2/3, IL2/4,
IFNG-3 (percentage), IFNG4 and IFNG8 (both absolute and percentage values). Using univariate ana-
lysis, the prevalence of positive HHV8 was signi¢cantly associated to endemic versus classic KS, KS
progression, decision of systemic therapy, KS staging, while it did not depend on the histologic type,
length of KS evolution, the presence of lymphedema and or painful KS lesions. Among immunolo-
gical parameters, only NK value tended without reaching signi¢cance to be associated with positive
HHV8 viremia. When all signi¢cant parameters were considered jointly in a multivariate analysis,
only KS progression remained signi¢cantly and independently associated with positive HHV8 vire-
mia. In conclusion, as observed in immunosupressed KS, positive HHV8 viremia is signi¢cantly asso-
ciated with progressive KS. A case control study using controls matched for age and sex is necessary
for de¢nitive interpretation of immunological ¢ndings.
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Autoantibodies to Various Epidermal Antigens Induced by Immunization of Nor-
mal Mice with Desmoglein 1: An Epitope Spreading Phenomenon?
H. Mouquet, L. Drouot, C. Arnoult, P. Joly, F. Tron and D. Gilbert
U519 INSERM, IFR 23 and service de Dermatologie, CHU Charles Nicolle ROUEN-FRANCE
In order to produce anti-desmoglein 1 (Dsg1) monoclonal antibodies (mAb), we have immunized
BALB/c and CD1 mice with recombinant extracellular domain of Dsg1. The recombinant protein
including the 5 domains EC1 to EC5, 6 Histidine and a FLAG peptide, was produced in insect cells
and puri¢ed with anti-FLAG antibodies by a⁄nity chromatography. For some immunizations the
protein was bound to KLH. Four fusion experiments were performed and hybridomas were screened
by IIF on cryostat sections of human foreskin and by ELISA using the recombinant protein.
We have obtained not only anti-Dsg1mAb, but also mAbs directed against basal membrane and/or
intercellular antigens. Four selected mAb were produced in ascitic £uids and puri¢ed. By western blot
analysis using human epidermis as substrate, one of them (CK1mAb) recognized polypeptides of 190-
210 kDa comigrating with periplakin and envoplakin. By IIF, this mAb stained both the basal mem-
brane and the intercellular space in super¢cial layers of epidermis, recalling the pro¢le obtained with
certain paraneoplastic pemphigus sera.
Two hypotheses can be proposed to explain these results : (i) natural antibodies against desmosomal
antigens constitute an idiotypic network, the balance of which is broken by anti-Dsg1 B cell clone
stimulation; (ii) anti-Dsg1 B cell clone presentation of desmosomal proteins belonging to multimole-
cular complex lead to the spreading of the immune response to other autoantigens.
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Evidence for a Desmoglein 1 Truncated Isoform and Study of its Implication in
Pemphigus Foliaceus
Mouquet H1, Leblond J1, Drouot L1, Leprince J2, Joly P3,Tron F1, Gilbert D1
1UniteŁ INSERM 519, Rouen.
2UniteŁ INSERM 413, Mont saint Aignan IFRMP 23.
3Service de dermatologie,
CHU de Rouen-France
Introduction: Pemphigus foliaceus (PF) is an autoimmune blistering skin disease mediated by autoanti-
bodies directed against desmoglein 1 (Dsg1). We found mRNA of the DSG1 gene that contains an
intronic insertion of 101 bp probably caused by alternative splicing. This insertion including a stop
codon could lead to the synthesis of a Dsg1 truncated isoform, comprising the EC1 domain, a part
of EC2 domain and carrying of a new epitope, INT6, encoded by intron 6.We raised the hypothesis
of a Dsg1 truncated isoform that could contribute to tolerance breakdown during PF.
Materials & Methods: Total RNAs extracted from healthy subject skin were used in RT-PCR to con-
¢rm the existence of 2 DSG1 transcripts and in quantitative RT-PCR (LightCyclert) to determine
their respective expression level. In order to detect this truncated isoform in human skin, we produced
polyclonal antibodies directed against an oligopeptide of the Dsg1 EC2 domain and against the INT6
peptide. To search for the presence of speci¢c autoantibodies against this isoform, we performed an
ELISA using INT6 peptide as antigen and synthetized the truncated isoform (EC1-2-INT6) by in vitro
transcription / translation.
Results: The 2 DSG1 transcripts were detected in the epidermis of all healthy subjects (n¼ 9), and
alternative transcripts containing the intronic insertion represent 10 to 30% of the total DSG1
mRNAs. The 2 DSG1 transcripts are also detected in primary culture of epithelial cells. The anti-
EC2 and anti-INT6 antibodies that recognize by immunoblot analysis the EC1-2-INT6 protein, react
with a protein of 26 kDa in human skin or epithelial cells extracts. A proteomic map obtained after
2D-PAGE separation allowed us to localize this protein, the identi¢cation of which by mass spectro-
metry is in course. PF sera (n¼ 30) did recognize neither the INT6 peptide using ELISA nor the EC1-
2-INT6 protein by immunoblot analysis.
Conclusion: We have demonstrated the existence of an alternative splicing of DSG1 transcripts and a
soluble epithelial protein of 26 kDa which could correspond to the Dsg1 truncated isoform.We didn’t
¢nd autoantibodies directed against the INT6 epitope. Nevertheless, this peptide could occur in the
activation of autoreactive T lymphocytes. Moreover, the study of DSG1 transcript expression in dif-
ferents lymphoid tissues and in particular the human thymus is still in progress.
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CD4þ Cytotoxic Lymphocytes are Present In Situ in Atopic Dermatitis Lesional
Skin
Nicolas Meyer, Martine Bagot, Armand Bensussan
INSERMU448, and Dermatology Department, Paris XII University de CreŁ teil, 94 010 CreŁ teil
Atopic dermatitis is a common skin disorder. Its exact pathogenesis remains unknown. The role of
CD4þ lymphocytes has been suggested, but functional and phenotypic studies of cell mediated cy-
totoxicity have yielded con£icting results. Our goal was to perform a phenotypic and functional ana-
lysis of cell mediated cytotoxicity of lymphocytes isolated from lesional skin of atopic dermatitis. T
cells have been extracted from fragmented punch biopsies in IL2 and IL4 supplemented RPMI/SAB
culture medium, and then expanded on PHA-Feeder. T-cells have been phenotyped by £ow cyto-
metric analysis, and have been tested for functional cytotoxic ability in CD3 redirected cultures
against P815 cells. We have extracted about 40. 106 cells, expressing the following phenotype:
CD3þ , CD4þ , NKG2dþ , Granzymeþ , CD56, CD158b, CD158el, NKB1. We did not
¢nd CD4þ /CD8þ double positive lymphocytes. The expanded cells were able to induce lysis of
P815 cells when redirected by anti CD3 antibodies. This study demonstrate for the ¢rst time the pre-
sence in lesional skin of atopic dermatitis of CD4þ lymphocytes with a phenotypic and a functional
cytotoxic activity. This cell population could be skin speci¢c and could be implicated in the lack of
peripheral immune tolerance in atopic dermatitis.
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Evidence and Characterization of Regulatory T-cells in Patients with Lymph Node
Metastatic Melanoma
M.Viguier1,2, F. Lema|“ tre1, O.VeŁ rola
3, A. Lim1, P. Kourilsky1, H. Bachelez2, L. Ferradini1
1Laboratoire de Biologie MoleŁ culaire du Ge' ne, Institut Pasteur;
2Service de Dermatologie I et Institut de Recherche
sur la Peau et 3Service d’Anatomopathologie, HoŒ pital Saint-Louis, Paris
Introduction: Regulatory T cells control the activity of other T lymphocytes (LT). They have been
shown to play an important role in the prevention of autoimmune diseases in mice and could neutra-
lize immune anti-tumor responses. Our aim was to identify and characterize such cells in melanoma
patients.
Patients and Methods: Ten patients were included. Lymphocytes were isolated from blood, metastatic
and non metastatic lymph nodes. CD4þCD25high LT were characterized ex vivo and functionaly
tested in vitro after cell sorting. TCRVb repertoire was studied by quantitative PCR and Immuno-
scope.
Results: When comparing metastatic lymph nodes with peripheral LT, we evidenced an increased per-
centage of CD4þCD25high LT (11.1%71.8% vs 5.5%71.8% from all CD4þ Tcells) with a DRlow
CD45ROþ CTLA-4þ phenotype.We showed that these LT had regulatory properties in vitro to-
ward the CD4þCD25 and the CD8þ LT in¢ltrating the same lymph node. They mainly dis-
played a polyclonal TCRVb repertoire.
Conclusions: Our data suggest the existence of regulatoryT cells in metastatic melanoma lymph nodes
which could potentially modulate the cytotoxic and helper activity of other LT.This could contribute
to explain the immune escape usually observed in this tumor.
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Analysis of the Evolution of Lesional Skin-In¢ltrating T Lymphocyte Repertoire
in HIV-infected Patients with Psoriasis
M. Kemula1,2; B. Flageul1; C. Parizot2; JM. Molina1; L. Dubertret1; G. Gorochov2; H. Bachelez1
1Institut de Recherche sur la Peau, UniteŁ INSERM U532, St-Louis hospital;
2Immunology laboratory, UniteŁ
INSERMU543 PitieŁ -SalpeŒ trie' re hospital, Paris
While some authors suggest the presence of a common antigens as a major activator of lesional skin-
in¢ltrating lymphocytes in psoriasis vulgaris (Prinz EJI 1999; Hwang JID 2003), our previous results
analysing repertoire (immunoscope) and function (phenotype, class I tetramer and ELISPOT) of psor-
iasis plaque-in¢ltrating CD8þ T lymphocytes in Human Immunode¢ciency Virus (HIV)-infected
individuals argue against the hypothesis of a cutaneous CD8þ T cell selection by HIV antigens (abst
028C J Invest Dermatol 2002;118(6)).
We selected a BV family displaying an oligoclonal pro¢le on immunoscope analysis and sequenced
the T cell receptor (TCR) CDR3 antigen recognition domain of psoriatic skin-in¢ltrating lympho-
cytes from 2 HIV-infected individuals at an interval of respectively 2 and 3 years. In both patients,
results con¢rm that plaque-in¢ltrating lymphocytes are oligoclonal. In one patient, 6 distinct clono-
types belonging to the BV16 family persist in relapsing psoriasis 3 years later. In the other patient, no
identity was found at a 2 year-interval. Nevertheless, one TCR BV4 rearrangement showed a single
amino-acid di¡erence in the CDR3 region with a TCR BV4 clonotype previously evidenced in skin
lesions.We report the long term persistence of particular TCR BVclonotypes in skin lesions of HIV-
related psoriasis, together with a high variability a¡ecting other speci¢cities. These data, even though
not excluding the role of a persistent antigenic stimulation, suggest that other mechanisms may parti-
cipate in the recruitment of T lymphocytes to lesional skin, such as epitopes varying with time, or
TCR-independent interactions like those implying chemokines and their receptors.
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Breadth of CD8þ T Lymphocytes Inducted in Rhesus Macaques Vaccinated with
NEF and GAG Lipopeptides is Dependant on Route of Immunization
Z. Coutsinos1, P.Villefroy1, H. Gras-Masse2, J.G. Guillet1 and I. Bourgault-Villada1
1Institut Cochin, INSERMU567, 75014 Paris, 2Institut Pasteur de Lille
Given the relevance of antigen administration route in the development of an e¡ective cellular im-
mune response, this study was designed to assess lipopeptide immunizations administered either by
the intramuscular (IM) or the intradermal (ID) routes in their ability to elicit GAG and NEF multi-
speci¢c CD8þ T-lymphocytes in the rhesus macaque.
Two groups of macaques were immunized either by the IM or ID routes with a mixture of 7 SIV-
lipopeptides derived from proteins NEF (5) and GAG (2). The animals were vaccinated thrice at 3-
week intervals and T-cell e¡ector responses directed against SIV-epitopic peptides, included in the
immunizing sequences were investigated by performing a sensitive IFNg ELISpot assay. Although
both groups yielded antigen-speci¢c responses 7/11weeks post-vaccination, there was an overall better
response in the ID-vaccinated group. Indeed, IM- immunized monkeys yielded IFNg secreting lym-
phocytes to no more than 2 pools of short peptides derived from SIV-NEF. In contrast, ID-immu-
nized macaques presented multispeci¢c IFNg secreting lymphocytes in response to as many as 4 pools
of short peptides derived from SIV-NEF and/or GAG.
Our results suggest that breadth of the cellular immune response is a¡ected by route.
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InVivo Containment of SIV Replication Associated with Induction of Broad Multi-
Speci¢c Cytotoxic T Lymphocytes Directed Against Conserved Viral Epitopes
P.Villefroy1, F. Letourneur1, Z. Coutsinos1, L. Mortara1, C. Beyer2, H. Gras-Masse3, J.G. Guillet1,
I. Bourgault-Villada1
1Institut Cochin, INSERM U567, 75014 Paris, 2Institut deVirologie, Strasbourg, 3Institut Pasteur de Lille
We investigated the role of multispeci¢c cytotoxic T lymphocytes (CTL) responses induced by a li-
popeptide simian immunode¢ciency virus (SIV) vaccine in protecting rhesus macaques from a highly
pathogenic SIVmac251 challenge. Prior to intravenous challenge, two vaccinated macaques displayed
multispeci¢c CTL directed against 4 and 6 NEF and GAG epitopes, respectively. The macaque with
the broadest CTL speci¢cities (3 of 6 epitopes were perfectly conserved within SIVmac251) controlled
viral replication following challenge, with plasma RNA levels remaining undetectable throughout a 2
year follow-up, stable CD4þ T-cell counts, no emergence of escape variant viruses and no sign of
AIDS. In contrast, the macaque with CTL directed against 4 SIV epitopes of which only one was
perfectly conserved, had plasma RNA levels that remained permanently high with, however, a de-
layed onset of disease. These data highlight the crucial in vivo role of potent broad multispeci¢c CTL
responses in setting a very low and steady viral set point associated with containment of SIV quasis-
pecies variants and disease control.
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Gene Therapy of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Y. Gache1, C. Baldeschi1, P. BouilleŁ
2, M. Del Rio3, L. Bruckner-Tuderman4, J.P. Ortonne1,
G. Meneguzzi1
1INSERM U385, Nice; 2Genethon III, Evry, France; 3CIEMAT, Madrid, Spain; 4Dept. of Dermatology,
University of Munster, Germany
Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited skin disorder caused by mutations
in collagenVII, the major component of the dermal anchoring ¢brils. RDEB is characterized by skin
blistering, abnormal healing, contractures and cancers. No conventional treatment is yet available.
Gene therapy for RDEB appeared until now di⁄cult to realize because of the large size of the col-
lagenVII cDNA (9 kb) and the absence of an animal model suitable to preclinical trials.
Since MoMLV retroviruses are the most used vectors for gene therapy, we assessed their suitability
to correct the genetic defect of keratinocytes of patients with RDEB. The collagenVII cDNA (9 kb)
cloned into a pLZRS retrovirus backbone was transduced into primary collagenVII-null RDEB ker-
atinocytes. The e⁄cient gene transfer resulted in: -1) secretion of the recombinant polypeptide that
displayed the structural properties of the wild-type collagenVII, -2) loss of the hypermotility charac-
teristic of the RDEB cells; -3) e⁄cient deposition of collagenVII at the dermal-epidermal junction of
skin made with the reverted keratinocytes and an arti¢cial skin equivalent. The arti¢cial skin grafted
onto SCID mice generated a basement membrane with mature hemidesmosomes and anchoring ¢-
brils. This approach of genetic therapy was validated in a spontaneous animal model of RDEB dog in
which collagen VII with a missense mutation is assembled in abnormal anchoring ¢brils. Ex vivo
transduction of the dog RDEB keratinocytes with MoMLVretroviruses expressing the dog wild-type
collagenVII cDNA and construction of arti¢cial skin achieved the full reversion of the RDEB phe-
notype.
Our results show that currently utilized retroviral vectors e⁄ciently transfer the large collagenVII
cDNA into primary RDEB keratinocytes and produce transplantable epithelia expressing the curative
transgene.
The RDEB dogs o¡er the possibility of preclinical testing of therapies based on collagenVII gene
replacement in immune competent hosts.
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Di¡erential Degradation of Allelic Forms of P53 after UV-B Irradiation by Speci¢c
E6 Mutants from Cutaneous Human Papillomavirus Type 5
Olivier Humbey1, Ayodele Ola2, Franc ois Aubin1, Alan Storey2
1Dpt of Cell Biology, EA3181, IETG, Besanc on, France, 2SkinTumour Laboratory, Cancer Research UK, London,
United Kingdom
Although the molecular mechanism is now clearly established in the case of cervical cancer, the po-
tential oncogenic role of cutaneous human papillomaviruses (HPV) in skin carcinoma is poorly un-
derstood. In a previous study, we showed that a common polymorphism at codon 72 of p53, encoding
either an Arginine (Arg) or Proline (Pro) residue, may be a risk factor for transplant recipients to
develop skin cancer. Here, we examined the ability of di¡erent E6 mutants obtained from cutaneous
HPV to bind or to degrade both allelic forms of p53-72 in di¡erent cell lines after UV-B radiation.
Site-directed mutagenesis was used to generate 11 speci¢c mutations in the HPV5 E6 gene, an epider-
modysplasia verruciformis (EV) HPV type. The mutations were introduced in amino acids that di¡er-
entiated between di¡erent HPV types, and fell into three distinct groups based on protein sequence
homology amongst EV, cutaneous and mucosal HPVs. The di¡erent HPV E6 plasmids were then
transfected alone into either HT1080 (wild type p53, Pro/Arg heterozygous), or together with either
a p53Pro or p53Arg expression plasmid into the p53-null cell lines Saos2 and RTS3b. Following UV-
B irradiation, extracts were prepared and p53 protein levels analysed by western blotting. Analysis of
the E6-transfected cells revealed that in contrast to wild type HPV5 E6, 7 of the 11 HPV5 E6 mutant
proteins had an altered biological activity and were able to promote p53 degradation. Furthermore,
these mutants displayed marked di¡erences in their ability to stimulate the degradation of the p53 Pro
and Arg isoforms, showing a speci¢c preference for the p53Pro compared to the p53Arg form.
Although prototype E6 proteins from cutaneous HPV are believed to be unable to degrade p53, our
results show that speci¢c E6 mutants from the cutaneous HPV type 5 have a gain of function by
degrading the tumour suppressor protein p53. In addition, our results suggest a particular association
between speci¢c cutaneous E6 mutants and a preferential degradation of one of the p53Pro isoform
that may, in part, explain why some HPV-infected transplant patients show an association between
their TP53 genotype and risk of skin cancer development.
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Withdrawn.
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Signi¢cant Association of Polymorphism GLN27 GLU OF 2-Adrenergic Receptor
and Psoriasis
Roguedas AM1,2, Audrezet MP2, DupreŁ D
1,2, Scotet V2, Ferec C2, Misery L1
1Service de dermatologie, 2INSERM-EMI 0115, Laboratoire de GeŁ neŁ tique MoleŁ culaire, CHUMorvan, Brest
Stress is the most frequent triggering factor of psoriasis. Stress induces the release of catecholamines,
which have a high a⁄nity for 2 adrenergic receptors. 2 adrenergic receptors are expressed on Lan-
gerhans cells, keratinocytes and lymphocytes, which are cells involved in the pathophysiogeny of psor-
iasis. Four polymorphismes (located in 16, 27, 34 et 164) are responsible for modi¢cations of the
functioning of these receptors.We have searched for a possible association of polymorphism 16 and
27of this receptor gene with psoriasis.
Our study has been performed in 56 patients su¡ering from psoriasis. After DNA extraction, the
genotyping was done by PCR and direct sequencing of candidate genes. Statistical analysis was rea-
lised with Epi-Info 6 04 for  2 test.
We did not reveal any di¡erence of the Gly16Arg with normal Caucasian subjects. But our data
supported an signi¢cant association of the Gln27Glu with psoriasis (p¼ 0.0026) with an odd-ratio of
0.41(0.22-0.77).
This polymorphism is known to induce a downregulation of receptor expression. In patients with
psoriasis, the e¡ects of catecholamines are probably decreased, whereas they are able to modulate acti-
vation of T cells and induce di¡erentiation of keratinocytes. Hence, the presence of this polymorph-
ism might be implicated in the pahophysiogeny of psoriasis.
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Hypotrichosis Simplex of the Scalp is Caused by Nonsense Mutations in the Cor-
neodesmosin Gene (CDSN)
E. Levy-Nissenbaum1, R.C. Betz2, M. Frydman1, M. Simon3, H. Lahat1,T. Bakhan1, B. Goldman1, A.
Bygum4, M. Pierick5, A.M. Hillmer5, N. Jonca3, J. Toribio6, R. Kruse7, G. Dewald5, S. Cichon2, C.
Kubisch5, M. Guerrin3, G. Serre3, M.M. N˛then2, E. Pras1
1Danek Gartner Institute of Human Genetics,Tel Hashomer, Israel andTel Aviv University,Tel Aviv, Israel;
2University of Antwerp, Antwerp, Belgium; 3CNRS FRE2623,Toulouse, France; 4Odense University Hospital,
Odense, Denmark; 5Institute of Human Genetics, Bonn, Germany; 6University of Santiago de Compostela,
Santiago de Compostela, Spain; 7University of Dˇsseldorf, Dˇsseldorf, Germany
Hypotrichosis simplex of the scalp (HSS; MIM 146520) is an autosomal dominant form of nonsyn-
dromic alopecia. From early puberty, patients start losing scalp hair, progressing to an almost complete
alopecia by their early twenties. HSS has been previously mapped to chromosome 6p21.3.
Using a positional candidate gene approach, we identi¢ed nonsense mutations in the CDSN gene
in three HSS families of various ethnic origin. CDSN is a late di¡erentiation epidermal glycoprotein
thought to function as a keratinocyte adhesion molecule. It is also expressed in the inner root sheath
of hair follicles.
Histological, immunohistological and western-blotting analyses performed on patient scalp biop-
sies revealed an accumulation of a truncated form of CDSN, probably as protein aggregates, in the
super¢cial dermis and at the periphery of hair follicles in the lower dermis.
Our results identify mutations in CDSN as the genetic lesions underlying HSS, and suggest a cri-
tical role for CDSN in the development and integrity of scalp hair follicles.
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Cowden Syndrome with Proteus-Like Manifestations Recurrence of Secondary
Alterations as PTEN Allelic Defect in Lesional Skin
F. Caux1, O. Fain2, M. Gerard3, L. Laroche1, M. Longy4
1Service de Dermatologie et UPRES EA 3408, C.H.U., 93000 Bobigny; 2Service de MeŁ decine Interne, 93140
Bondy; 3GeŁ neŁ tique MeŁ dicale, CHIC, 94000 CreŁ teil;
4Laboratoire d’Oncologie MoleŁ culaire, Institut BergonieŁ, 33000
Bordeaux, France
Mosaicism is the phenomenon in which a fraction of cells of an organism contain a mutation. Seg-
mental manifestations of autosomal dominant diseases can be explained by this mechanism which is
rarely demonstrated in human disorders.We searched for this phenomenon in a woman a¡ected by
complex manifestations and belonging to a family of Cowden disease with PTEN gene mutation.
In this family followed over three generations, 1 out of 2 was a¡ected at the ¢rst generation, 3 out
of 6 at the second generation and 2 out of 7 at the third generation. A PTEN germline mutation
(heterozygous A-G transition at codon 403 leading to an isoleucine-to-valine substitution in posi-
tion 135) was found in the 6 a¡ected individuals. Five out of six patients presented clinical features
typical of Cowden syndrome. The last patient had a complex phenotype associating classic manifesta-
tions of Cowden syndrome and congenital dysmorphia with segmentary lipomatosis, hemolymphan-
giomas, overgrowth of lower limbs and epidermal naevi following Blaschko’s lines.
To better understand this complex phenotype, two biopsies of lesional skin were performed on the
left lower leg and DNAwas extracted. No second hit mutation was found in the 9 exons of PTEN
gene. Microsatellite genotyping analysis using 6 markers of chromosome 10 in PTEN region was per-
formed. Loss of heterozygosity was observed in both skin DNA but was absent in blood lymphocytes
DNA. On the other hand no loss of heterozygosity was found in DNA of 15 biopsies of lesional
tissues performed in other patients with Cowden syndrome.
The complex phenotype of our patient evoked Proteus syndrome or Klippel-Trenaunay syndrome.
Germline mutation and a second hit mutation of PTEN in lesional tissues has previously been de-
monstrated in a patient with a Proteus-like syndrome. Clinical data of our patient could similarly be
explained by a germline mutation of PTEN associated with an interstitial deletion of chromosome 10
in lesional skin.
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New Type of Mutation of the Cyld Gene and Tumor Progression in the Brooke
Spielger Syndrome
M Bergis, Sophie Queille, B Chapelier, M Burnouf, C Lalou, M. Lafha, E Roux, P Gorry, L Dubertret,
N Basset-SeŁ guin
IRP, U532, HoŒ pital Saint-Louis, Paris
Brooke Spielger syndrome (BSS) is an autosomal dominant genodermatosis characterized by the de-
velopment of multiple adnexal benign tumors such as cylindromas, trichopeitheliomas ans spiradeno-
mas. The candiate gene, CYLD, has been recently identi¢ed. In this work we have analyzed genetic
events implicated in the tumoral progression of BSS in 7 di¡erent tumors of the same patient: 2 cy-
lindroma, 2 trichoepithelioma, 2 spiradenoma, and one cylindrocarcinoma, a rare but serious compli-
cation of BSS. In order to con¢rm that this patient had indeed a BSS, the 20 exons of the CYLD gene
were analyzed by direct sequencing and PCR SSCP. This analysis revealed a previously known C4T
polymorphism in exon 18 but no mutation of the coding sequences were identi¢ed. However, the
polymorphism allowed us to 1) show a decrease in the level of messenger RNA carrying the C allele
only in the patients but not in the healthy individuals of the family suggesting a decreased in the
transcription or stability of the mutated allele. 2) to identify a loss of heterozygozity (LOH) of the
CYLD gene in all tumor analyzed suggesting that it is an early phenomena. No mutation nor methy-
lation of the p16ink4-ARF locus was observed. A mutation of the p53 gene (codon 196) in the cylin-
drocarcinoma associated with an overexpression of Gli by RT^PCRwere detected. Analysis of the
PATCH1 gene by HPLC showed an insertion of 4 nucleotides in exon 5 associated with a LOH for
the PATCH1 gene polymorphism in exon 23, suggesting a bi-allelic loss of the PACH1 gene in this
tumor. This work shows that non-coding regions of the CYLD gene can be targeted in the BSS. An
analysis of non-coding sequences and promotor regions of the CYLD gene is currently performed.
Tumoral development in BSS requires LOH for CYLD and malignant progression of cylindroma is
associated with inactivation of both p53 and PATCH1 genes in this patient.
C38
Joint E¡ects of MC1R Gene, Naevus Phenotypes and Sun-Related Covariates on
CKDN2A Penetrance in French Melanoma-Prone Families
V. Chaudru1, A. Chompret2, A. Minie' re2, K. Laud2, M.F. Avril2, B. Bressac-de Paillerets2, F. Demenais1
1INSERM-UniversiteŁ d’Evry, EMI 0006, Evry, France;
2Institut Gustave Roussy,Villejuif, France
Cutaneous malignant melanoma (CMM) is an heterogeneous and complex disease resulting from
many genetic and environmental factors. Germline mutations in the CDKN2A gene confer a substan-
tial risk of melanoma in at most 50% of melanoma-prone families worldwide. Variants of MC1R
(melanocortin-1 receptor gene) have been found associated with red hair and fair skin and were also
reported to contribute to melanoma risk independently of its e¡ect on skin type. Other factors in-
cluding nevus phenotypes (total number of nevi, dysplastic nevi), pigmentary traits (skin, hair and eye
color), skin reactions to sunlight and degree of sun exposure, also in£uence melanoma risk. Two re-
cent studies have indicated that MC1R modi¢es melanoma risk in Australian and Dutch families seg-
regating CDKN2A mutations [Box et al., Am. J. Hum. Genet., 2001; van der Velden et al., Am. J.
Hum. Genet., 2001]. However, other risk factors, except skin type, were not taken into account in
these analyses. Our goal was to examine the joint e¡ects of MC1R variants (R151C, R160W,
D294H), nevus phenotypes, pigmentary traits and sun-related covariates on CDKN2A penetrance.
Clinical, genetic, and covariate data were recorded in 53 French melanoma-prone families of which
20 had co-segregating CDKN2A mutations. Analysis of the co-transmission of CMM and CDKN2A
mutations was conducted by likelihood-based methods using the regressive logistic models which can
account for a variation of disease risk with age and can include the aforementioned risk factors as
covariates. Including MC1R as the only covariate in the model increased substantially CMM risk in
carriers and non-carriers of CDKN2A mutations (OR¼ 6.6, 95% CI 6.1^7.2). This increase in risk,
although still signi¢cant, was reduced (OR¼ 2.3, 95% CI 2.1-2.5) when other signi¢cant covariates
were entered in the regression.The ¢ve covariates that modi¢ed signi¢cantly CDKN2A penetrance, in
addition toMC1R, were: number of nevi (OR¼ 2.1), dysplastic nevi (OR¼1.8), fair skin (OR¼ 0.8),
propensity to sunburn (OR¼ 4.7) and sun exposure (OR¼1.7). Interestingly, while all these factors
increased CMM risk, fair skin had a protective e¡ect in presence of MC1R. Our study underlines that
several pathways are likely to be involved in the development of malignant melanoma.
1578 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
